










<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> 





<!--[if lt IE 7]> <html class="no-js lt-ie10 lt-ie9 lt-ie8 lt-ie7" lang="en"> <![endif]-->
<!--[if IE 7]>    <html class="no-js lt-ie10 lt-ie9 lt-ie8" lang="en"> <![endif]-->
<!--[if IE 8]>    <html class="no-js lt-ie10 lt-ie9" lang="en"> <![endif]-->
<!--[if IE 9]>    <html class="no-js lt-ie10" lang="en"> <![endif]-->
<!--[if gt IE 9]><!--> <html class="no-js" lang="en"> <!--<![endif]-->

<!--[if !IE]> -->
<html xmlns="https://www.w3.org/1999/xhtml">
<!-- <![endif]-->

  <head>
  

 
    <title>Management of Withdrawal Syndromes and Relapse Prevention in Drug and Alcohol Abuse - - American Family Physician</title>
    
    <meta charset="utf-8" />
    <meta name="content-type" content="text/html; charset=UTF-8">
    <meta id="view" name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0"/>

  <link rel="shortcut icon" type="image/x-icon" href="//www.aafp.org/favicon.ico"/>
  <link rel="stylesheet" href="//css.aafp.net/journal-article/style.css" type="text/css" media="all" />       
  <link rel="stylesheet" href="/afp/css/journal.css" type="text/css" media="all" />
     
    <script type="text/javascript" src="//js.aafp.net/JavaScriptFinal.js"></script>   
  <script src="//nf.aafp.org/ScriptManager/Scripts/Aafp.Core.js" type="text/javascript" xmlns:xlink="https://www.w3.org/1999/xlink"></script>
  <script type="text/javascript" src="//www.aafp.org/jquery.printElement.js"></script>
     
  <!-- Ad Config for Synchronous Google Publisher Tags -->
<script type="text/javascript">
 (function() {
   var useSSL = 'https:' == document.location.protocol;
   var src = (useSSL ? 'https:' : 'http:') + '//www.googletagservices.com/tag/js/gpt.js';
   document.write('<scr' + 'ipt src="' + src + '"></scr' + 'ipt>');
 })();
</script>
    <meta name="description" content="The primary care physician is in a good position to diagnose, manage and intervene with patients who are undergoing the process of treatment and recovery from alcohol and drug disorders. Medications such as benzodiazepines are effective in the treatment of withdrawal syndromes, and naltrexone and disulfiram can be used to augment relapse prevention. Patients may also participate in psychosocial methods of addiction treatment that can reduce the risk of relapse and improve their psychosocial, health, legal and employment status." />
<meta name="pubdate" content="1998-07-01" />
<meta name="access-restricted" content="false" />
<meta name="content-type-facet" content="Article" />
<meta name="author" content="Norman S. Miller|Mark S. Gold" />
<meta name="topic" content="Substance Abuse|Alcohol Abuse and Dependence" />
<meta name="discipline" content="Psychiatric and Psychologic" />
<meta name="population" content="" />
<meta name="content-focus" content="Treatment|Prevention" />
<meta name="journal-tools" content="" />
<meta name="journal-tool-icons" content="" />
<meta name="image" content="" />
<meta name="collection-sublinks" content="" />
<meta name="collection-subitems" content="" />



	<meta content="American Family Physician" name="citation_journal_title" />
	<meta content="AFP" name="citation_journal_abbrev" />
	<meta content="0002-838X" name="citation_issn" />
	<meta content="1532-0650" name="citation_issn" />

	
		<meta name="citation_fulltext_world_readable" content=""/>
	
	<meta content="Management of Withdrawal Syndromes and Relapse Prevention in Drug and Alcohol Abuse" name="citation_title" />
	<meta content="1998/07/01" name="citation_publication_date" />
	<meta content="58" name="citation_volume" />
	<meta content="1" name="citation_issue" />
	<meta content="139" name="citation_firstpage" />

	

	

	
	<meta content="The primary care physician is in a good position to diagnose, manage and intervene with patients who are undergoing the process of treatment and recovery from alcohol and drug disorders. Medications such as benzodiazepines are effective in the treatment of withdrawal syndromes, and naltrexone and disulfiram can be used to augment relapse prevention. Patients may also participate in psychosocial methods of addiction treatment that can reduce the risk of relapse and improve their psychosocial, health, legal and employment status." name="citation_abstract"/>
	

	
	
		<meta name="citation_author" content="Norman S. Miller" />
	
		<meta name="citation_author" content="Mark S. Gold" />
	
	


<!-- Begin Open Graph -->
	<meta property="og:title" content="Management of Withdrawal Syndromes and Relapse Prevention in Drug and Alcohol Abuse" /> 
	<meta property="og:description" content="The primary care physician is in a good position to diagnose, manage and intervene with patients who are undergoing the process of treatment and recovery from alcohol and drug disorders. Medications such as benzodiazepines are effective in the treatment of withdrawal syndromes, and naltrexone and disulfiram can be used to augment relapse prevention. Patients may also participate in psychosocial methods of addiction treatment that can reduce the risk of relapse and improve their psychosocial, health, legal and employment status." /> 

       
   
    <meta property="og:image" content="https://www.aafp.org/dam/AAFP/images/journals/afp-brand.png" />
   
 	
 	
	 	<meta name="twitter:card" content="summary_large_image">
		<meta name="twitter:site" content="@aafp">
		<meta name="twitter:title" content="Management of Withdrawal Syndromes and Relapse Prevention in Drug and Alcohol Abuse" />
		<meta name="twitter:description" content="The primary care physician is in a good position to diagnose, manage and intervene with patients who are undergoing the process of treatment and recovery from alcohol and drug disorders. Medications such as benzodiazepines are effective in the treatment of withdrawal syndromes, and naltrexone and disulfiram can be used to augment relapse prevention. Patients may also participate in psychosocial methods of addiction treatment that can reduce the risk of relapse and improve their psychosocial, health, legal and employment status." />

       
   
    <meta property="twitter:image" content="https://www.aafp.org/dam/AAFP/images/journals/afp-brand.png" />
   
 	
	<!-- END Open Graph -->

  





<script type="text/javascript" src="//js.aafp.net/omniture/aafp-prod-omniture.js"></script>
<script type="text/javascript"><!--

    
    var memberIdSC = getMemberIdEnCodedWithCookie();

/* Traffic Variables */
	s.pageName="journals:afp:19980701:139";

	s.referrer=document.referrer

	s.prop1= "management of withdrawal syndromes and relapse prevention in drug and alcohol abuse";
	s.prop3 = "american family physician";
	s.prop14=memberIdSC

    s.prop17= "public";

	s.prop40= "publications"
	s.prop41= "educate"
	s.prop42= "jms"

/* eVars */
	s.eVar21="";
	s.eVar41= "D=c41"
    s.eVar42="D=c40"

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
	var s_code=s.t();if(s_code)document.write(s_code)//-->
	</script>




  







  
        
          <script type='text/javascript'>
	  var mapping = googletag.sizeMapping().
      addSize([0, 0], [320, 50]).
      addSize([768, 125], [728, 90]).
      build();
	  var rightAdMapping = googletag.sizeMapping().
	  addSize([0, 0], []).
      addSize([768, 125], [[300, 250], [300, 600]]).
      addSize([1050, 200], [[300, 250], [300, 600]]).
      build();
	googletag.defineOutOfPageSlot('/136646342/afp/issue_content', 'div-gpt-ad-interstitial').addService(googletag.pubads());
	googletag.defineSlot('/136646342/afp/issue_content', [300, 250], 'div-gpt-ad-right').defineSizeMapping(rightAdMapping).setCollapseEmptyDiv(true).addService(googletag.pubads());
	googletag.defineSlot('/136646342/afp/issue_content', [728, 90], 'div-gpt-ad-leaderboard').defineSizeMapping(mapping).setTargeting('position',['atf']).setCollapseEmptyDiv(true).addService(googletag.pubads());

    googletag.pubads().setTargeting('rprof', 'null');
    
   	googletag.pubads().setTargeting('cgen', null);
   	googletag.pubads().setTargeting('cdis', ['psychiatric_and_psychologic']);
    googletag.pubads().setTargeting('ctop', ['substance_abuse', 'alcohol_abuse_and_dependence']);
    googletag.pubads().setTargeting('cpop', null);
    googletag.pubads().setTargeting('cfoc', ['treatment', 'prevention']);

    googletag.pubads().setTargeting('ctyp', 'articles');
    googletag.pubads().setTargeting('reffererurl', 'no');
    googletag.pubads().enableSyncRendering();
    googletag.enableServices();
</script>

        
        
      
  



	
	<link rel="canonical" href="https://www.aafp.org/afp/1998/0701/p139.html"/>

    <style type="text/css">
.jModal, #dialog-form{display:none;}
     #column-wrap { 
  width: 300px; 
  margin: 15px auto; 
  position: relative; 
}
    </style>  
    
     <!--[if lt IE 9 ]>
     <style type="text/css">
     .gtIE8, .mjToggle, .articleSections{display:none !important;}
     .ltIE8{display:block !important;}  
    
     </style>
        <![endif]-->

<!--[if gte IE 9]>
  <style type="text/css">
    #gradientColor {
       filter: none;
    }
  </style>
<![endif]-->
    
  </head>

<body class="journal-template is-signed-out">



    <div id="div-gpt-ad-interstitial">
  <script type='text/javascript'>
    googletag.cmd.push(function() { googletag.display('div-gpt-ad-interstitial'); });
  </script>
</div>

<div class="leaderboardAd adleaderboard" style="">
<div class="leaderboardAdRow">
  <div class="leaderboardAdContainer" style="">
    <div id="div-gpt-ad-leaderboard" style="">
    <a href="https://www.aafp.org/journals/afp/advertisers/rates-policies/online-policies.html" class="advert-title"  target="_blank">Advertisement</a><br/>
      <script type='text/javascript'>
        googletag.cmd.push(function() { googletag.display('div-gpt-ad-leaderboard'); });
      </script>
  	</div>
  </div>
  </div>
</div>

	    
	    
	  



<script type="text/javascript" src="//www.aafp.org/journals/afp.header.js"></script>

       <script>
   		var cmeUrl = "";
		var hasCredit = "";
		var electiveCredit = "";
		var prescribedCredit = "";
		var creditExpiry = "";
		var hasIssueAccess = "";
		var uCookie = getCookie("U");
   		
		function getCmeInfo(){
				
		var restUrl = "//www.aafp.org/rest/journal/AFP581/getcreditinfo";
	
		if(uCookie != null &&  uCookie.length > 0){
			restUrl += "byuser/"+ uCookie;
		}
			try{
				$( document ).ready(function() {  
					jQuery.ajax({
						type: "GET",
						url: restUrl,
						cache: false,
						dataType: "xml",
						success: function(xml) {
								cmeUrl = jQuery(xml).find("AssessmentUrl:first").text();
								hasCredit = jQuery(xml).find("HasCredit:first").text();
								electiveCredit = jQuery(xml).find("ElectiveCredit:first").text();
								prescribedCredit = jQuery(xml).find("PrescribedCredit:first").text();
								creditExpiry = jQuery(xml).find("EndDate:first").text();
								hasIssueAccess = jQuery(xml).find("HasAccess:first").text();
								updateCmeBox();
						}
					});
				});	
			}
			catch(e){
				alert("error - " + e);
			}
		}
	</script>
      


        
        <div id="main" class="page-wrap">


		<script> 
	var accTyp = "OPEN";  
	var metaRestrict = "false";
	
	

	var commentHandle = "/afp/1998/0701/p139";
	
	  </script>
	
	

	
	 

	<section id="content" class="main-content" role="main">

		<div class="bucket wide">

			<div class="block eight-column wide drop-shadow no-margin">

 






<div class="pvNxContainer" style="padding: 0 10px 6px 10px">
         
    <div class="prevCol">
 
<a id="prevArticle" href="/afp/1998/0701/p130.html" alt="Indications for Anticoagulation in Atrial Fibrillation" title="Indications for Anticoagulation in Atrial Fibrillation"> 
&lt;&lt;&nbsp;Previous <span class="hideMobileOnly">article</span></a>


    </div>
    <div class="nextCol">
    
<a id="nextArticle"  href="/afp/1998/0701/p153.html" alt="Assessment of Abnormal Growth Curves" title="Assessment of Abnormal Growth Curves">
Next <span class="hideMobileOnly">article</span>&nbsp;&gt;&gt;
</a>

    </div>
    <div class="tocCol">
   <a href="/afp/1998/0701/" alt="Jul 01, 1998 Issue" title="Jul 01, 1998 Issue">Jul 01, 1998 <span class="hideMobileOnly">Issue</span></a>
    </div>

                
                     
</div>

<script>

$(document).ready(function(){
    $('#prevArticle').unbind("click").bind("click", function (event) {
    	sconclickevent('AFP Previous Page'); 
    });
    $('#nextArticle').unbind("click").bind("click", function (event) {
    	sconclickevent('AFP Next Page');
    });
});
</script>





				<div class="white-background full-article">


  <div class="clearfix">
                    <span style="line-height:0px;">&#160;</span>
                  </div>



                     <?xml version="1.0" encoding="iso-8859-1"?><script xmlns:xlink="http://www.w3.org/1999/xlink" type="text/javascript">
     
          $(function () {
          var titleGroup =  $(".titleGroup").clone();
          var journalCopyright =  $(".journalCopyright").clone();


          var screen_width = $(window).width();
          var screen_height = $(window).height();

          if (screen_width >= 767) { var winW = 650 }

          else if (screen_width < 767 & screen_width > 479) {

            var winW = screen_width - 50;
        }
        else {
            var winW = screen_width - 20;
        };

        if (screen_height > 600) {

            var winH = 500;
        }
        else {
            var winH = screen_height - 50;
        };




        $(".jModal").dialog({
            autoOpen: false,
          
            modal: true,
            resizable: true,
            width: winW,
            height: winH,
            position: {
                my: "center",
                at: "center",
                of: window
            },
            buttons:                 
                {
                    'Close': function() {
                       //do something
                       $(this).dialog('close');
                    },
                    
                    
                
                   
                  
                   'Print': function(){
                	
                	  var printDialog = $(this).dialog().clone();
                	  $(titleGroup).find("h1.article-title").css('font-size', '28px');
                	  $(titleGroup).prependTo(printDialog).end();                	  
          			  $(journalCopyright).css('display', 'block').appendTo(printDialog).end();
          			  $(printDialog).find("a").removeAttr("href");
				
                	   $(printDialog).printElement(
                				
                			   
                	            {pageTitle:'',
                	               
                	                printBodyOptions:
                	                {
                	                styleToAdd:'width:auto;margin:15px;background-color:#ffffff !important;}',
                	                classNameToAdd : 'printVersion'
                	                },
                	               
                	                        
                	       
                	                            		 leaveOpen:true,
                	                 	                printMode:'popup'}
        
                    
                	   );
                

                	  
                       
                    },
                  
                  
                  },
        
            open: function (event, ui) {
            	

                $('.ui-widget-overlay').bind('click', function () { $(this).siblings('.ui-dialog').find('.ui-dialog-content').dialog('close');});
               
              
             
                
             $(this).focus()
              $(this).scrollTop(0);
            }
        });


        $("a[class='jOpener']").click(function (event) {
            var nameof = $(this).attr("name");
            $(".jModal[name=" + nameof + "]").dialog('open');
          
        });

        $("div[class='.jModal']").attr("style", "display:block;");
    });


</script><div xmlns:xlink="http://www.w3.org/1999/xlink" class="articleContent afp"><div class="clearfix"><span style="line-height:0px;"> </span></div><div class="afpContent" style="padding-bottom:10px"><div class="titleGroup"><h1 class="article-title">Management of Withdrawal Syndromes and Relapse Prevention in Drug and Alcohol Dependence</h1></div><div id="shareToolsLocation"> </div><div class="afpContent"><div class="cmeMobile" style="display:none;"> </div></div><div align="center"><div class="outline" style="margin-top:10px;width:275px;"><p><a href="#afp19980801p139-c1">This is a corrected version of the article that appeared in print.</a></p></div></div><script>
                          $(document).ready(function(){
                          var refLink = window.location;
                          $('a.loginLink').attr('href','https://www.aafp.org/cgi-bin/lg.pl?redirect=' + refLink);
                          $('a.buyLink').attr('href','https://nf.aafp.org/Shop/single-issue-cme/' + buyName);
                          });
                      </script></div><div class="afpContent"><p class="byline no-margin">NORMAN S. MILLER, M.D, University of Illinois College of Medicine, Chicago, Illinois</p><p class="byline no-margin">MARK S. GOLD, M.D, University of Florida Brain Institute, Gainesville, Florida</p><p class="self-citation"><i>Am Fam Physician.</i> 1998 Jul 1;58(1):139-146.</p><p class="blurb"/><div style="display:none;"><div id="floatNavLinks"><ul class="bold"><li><a class="floater" href="#abstract" alt="Abstract">
                                Abstract
                            </a></li><li><a class="floater" href="#sec-1">Pharmacotherapy for Withdrawal Syndromes</a></li><li><a class="floater" href="#sec-2">Benzodiazepines and Other Sedative/Hypnotics</a></li><li><a class="floater" href="#sec-3">Stimulants (Cocaine, Amphetamines and Derivatives)</a></li><li><a class="floater" href="#sec-4">Phencyclidine and Other Psychedelic Agents</a></li><li><a class="floater" href="#sec-5">Medications for Relapse Prevention</a></li><li><a class="floater" href="#sec-6">Use of Psychosocial Addiction Treatment to Prevent Relapse</a></li><li><a class="floater" href="#ref-list-1"><span id="floatRefLink">References</span></a></li></ul></div></div><div class="noPrint articleSections"><h3>Article Sections</h3><ul><li><a href="#abstract" alt="Abstract">
                                                Abstract
                                            </a></li><li><a href="#sec-1">Pharmacotherapy for Withdrawal Syndromes</a></li><li><a href="#sec-2">Benzodiazepines and Other Sedative/Hypnotics</a></li><li><a href="#sec-3">Stimulants (Cocaine, Amphetamines and Derivatives)</a></li><li><a href="#sec-4">Phencyclidine and Other Psychedelic Agents</a></li><li><a href="#sec-5">Medications for Relapse Prevention</a></li><li><a href="#sec-6">Use of Psychosocial Addiction Treatment to Prevent Relapse</a></li><li><a id="mobRefLink" href="#ref-list-1">References</a></li></ul></div></div><div class="afpContent"><div class="abstract" id="abstract"><p>The primary care physician is in a good position to diagnose, manage and intervene with patients who are undergoing the process of treatment and recovery from alcohol and drug disorders. Medications such as benzodiazepines are effective in the treatment of withdrawal syndromes, and naltrexone and disulfiram can be used to augment relapse prevention. Patients may also participate in psychosocial methods of addiction treatment that can reduce the risk of relapse and improve their psychosocial, health, legal and employment status.</p></div><p>Nearly one half of the patients who visit a family practice have an alcohol or drug disorder. Primary care physicians have an opportunity to intervene at all stages during the course of addictive illness. Each stage can be characterized by types and severity of withdrawal and relapse prevention.<a class="superscript bibrRef" href="#afp19980701p139-b1">1</a><span class="superscript">&#x2013;</span><a class="superscript bibrRef" href="#afp19980701p139-b3">3</a> Management of alcohol and drug disorders includes assessment, intervention, prescription of medications, participation in specific addiction treatment strategies and monitoring of recovery.</p><div class="jSection" id="sec-1"><h2>Pharmacotherapy for Withdrawal Syndromes</h2><div class="mjToggle noPrint"><div class="mjHeader noPrint"><span style="margin:5px;" class="mobileSectionLink">Jump to section +</span></div><div class="mjContent noPrint"><ul><li><a href="#abstract" alt="Abstract">
                                    Abstract
                                </a></li><li><a href="#sec-1">Pharmacotherapy for Withdrawal Syndromes</a></li><li><a href="#sec-2">Benzodiazepines and Other Sedative/Hypnotics</a></li><li><a href="#sec-3">Stimulants (Cocaine, Amphetamines and Derivatives)</a></li><li><a href="#sec-4">Phencyclidine and Other Psychedelic Agents</a></li><li><a href="#sec-5">Medications for Relapse Prevention</a></li><li><a href="#sec-6">Use of Psychosocial Addiction Treatment to Prevent Relapse</a></li><li><a href="#ref-list-1">References</a></li></ul></div></div><h3>Detoxification</h3><p>Pharmacologic therapies are indicated for use in patients with addictive disorders to prevent life-threatening withdrawal complications such as seizures and delirium tremens, and to increase compliance with psychosocial forms of addiction treatment. Laboratory testing is indicated to assess the type and timing of drugs used addictively and to guide management of withdrawal and recovery.<a class="superscript bibrRef" href="#afp19980701p139-b4">4</a></p><h3>Alcohol</h3><p>Management of alcohol withdrawal is based on the patient's history and current clinical status. The single best predictor of the likelihood of future withdrawal symptoms when alcohol is concerned is the patient's previous history, e.g., the presence or absence of seizures or delirium tremens <span class="italic">(<a href="#afp19980701p139-t1">Table 1</a>)</span>.</p><div class="table-format" id="afp19980701p139-t1"><div class="calltoactionbox"><div class="jDialog highlights"><div class="container secondary"><div class="jDialogPrintHide"><p style="text-align:right;margin-bottom:6px;margin-top:4px;"><a class="jOpener" name="afp19980701p139-t1"><strong>View/Print Table</strong></a></p><div class="journalTable"><span class="table-label">TABLE 1</span><h4 class=" table-title&#xA;       ">Signs and Symptoms of Alcohol and Drug Withdrawal</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Drug</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Peak period</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Duration</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Signs</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Symptoms</span></th></tr></thead><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Alcohol</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">1 to 3 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 to 7 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Elevated blood pressure, pulse and temperature, hyperarousal, agitation, restlessness, cutaneous flushing, tremors, diaphoresis, dilated pupils, ataxia, clouding of consciousness, disorientation</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Anxiety, panic, paranoid delusions, illusions, visual and auditory hallucinations (often derogatory and intimidating)</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Benzodiazepines and other sedative/hypnotics</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Short-acting: 2 to 4 days Long-acting: 4 to 7 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Short-acting: 4 to 7 days Long-acting: 7 to 14 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Increased psychomotor activity, agitation, muscular weakness, tremulousness, hyperpyrexia, diaphoresis, delirium, convulsions, elevated blood pressure, pulse and temperature, tremor of eyelids, tongue and hands</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Anxiety, depression, euphoria, incoherent thoughts, hostility, grandiosity, disorientation, tactile, auditory and visual hallucinations, suicidal thoughts</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Stimulants (cocaine, amphetamines and derivatives)</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">1 to 3 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 to 7 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Social withdrawal, psychomotor retardation, hypersomnia, hyperphagia</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Depression, anhedonia, suicidal thoughts and behavior, paranoid delusions</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Opiates (heroin)</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">1 to 3 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 to 7 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Drug seeking, mydriasis, piloerection, diaphoresis, rhinorrhea, lacrimation, diarrhea, insomnia, elevated blood pressure and pulse (mild)</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Intense desire for drugs, muscle cramps, arthralgia, anxiety, nausea, vomiting, malaise</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">PCP/psychedelics</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Days to weeks</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Days to weeks</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Hyperactivity, increased pain threshold, nystagmus, hyperreflexia, hypertension and tachycardia, eyelid retraction (stare), agitation and hyperarousal, dry and erythematous skin, violent and self-destructive behaviors</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Anxiety, depression, delusions, auditory and visual hallucinations, memory loss, irritable and angry mood and affect, suicidal thoughts</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">PCP = phencyclidine</span>.</p></div></div></div></div><div class="jModal" title="TABLE 1" name="afp19980701p139-t1"><div class="tableModal"><span class="table-label">TABLE 1</span><h4 class=" table-title&#xA;       ">Signs and Symptoms of Alcohol and Drug Withdrawal</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Drug</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Peak period</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Duration</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Signs</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Symptoms</span></th></tr></thead><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Alcohol</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">1 to 3 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 to 7 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Elevated blood pressure, pulse and temperature, hyperarousal, agitation, restlessness, cutaneous flushing, tremors, diaphoresis, dilated pupils, ataxia, clouding of consciousness, disorientation</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Anxiety, panic, paranoid delusions, illusions, visual and auditory hallucinations (often derogatory and intimidating)</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Benzodiazepines and other sedative/hypnotics</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Short-acting: 2 to 4 days Long-acting: 4 to 7 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Short-acting: 4 to 7 days Long-acting: 7 to 14 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Increased psychomotor activity, agitation, muscular weakness, tremulousness, hyperpyrexia, diaphoresis, delirium, convulsions, elevated blood pressure, pulse and temperature, tremor of eyelids, tongue and hands</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Anxiety, depression, euphoria, incoherent thoughts, hostility, grandiosity, disorientation, tactile, auditory and visual hallucinations, suicidal thoughts</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Stimulants (cocaine, amphetamines and derivatives)</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">1 to 3 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 to 7 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Social withdrawal, psychomotor retardation, hypersomnia, hyperphagia</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Depression, anhedonia, suicidal thoughts and behavior, paranoid delusions</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Opiates (heroin)</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">1 to 3 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 to 7 days</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Drug seeking, mydriasis, piloerection, diaphoresis, rhinorrhea, lacrimation, diarrhea, insomnia, elevated blood pressure and pulse (mild)</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Intense desire for drugs, muscle cramps, arthralgia, anxiety, nausea, vomiting, malaise</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">PCP/psychedelics</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Days to weeks</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Days to weeks</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Hyperactivity, increased pain threshold, nystagmus, hyperreflexia, hypertension and tachycardia, eyelid retraction (stare), agitation and hyperarousal, dry and erythematous skin, violent and self-destructive behaviors</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Anxiety, depression, delusions, auditory and visual hallucinations, memory loss, irritable and angry mood and affect, suicidal thoughts</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">PCP = phencyclidine</span>.</p></div></div></div></div></div></div></div></div><p>Alcohol withdrawal may be treated with a pharmacologic agent that exhibits cross-tolerance with alcohol. Agents that are commonly recommended include diazepam (Valium), lorazepam (Ativan), chlordiazepoxide (Librium), clorazepate (Tranxeme) and phenobarbital. The usual initial dosage of diazepam or lorazepam is titrated according to elevations of blood pressure, pulse rate, degree of agitation and presence of delirium. In general, longer-acting preparations such as diazepam or chlordiazepoxide provide a smoother and safer withdrawal than other preparations. Shorter-acting preparations such as lorazepam are indicated when elimination time for benzodiazepines is prolonged, such as in patients with significant liver disease.</p><p>A loading dose of a long-acting benzodiazepine such as diazepam or chlordiazepoxide may be given initially, and the dosage may then be tapered. This method is often used in conjunction with a scale for detoxification. It is also used frequently in an inpatient setting. The physician should screen the patient for the presence of other sedating drugs to avoid untoward drug interactions, particularly oversedation. Initial loading doses for diazepam are in the range of 30 to 50 mg. Suggested parameters and dosages are presented in <span class="italic"><a href="#afp19980701p139-t2">Table 2</a></span>.</p><div class="table-format" id="afp19980701p139-t2"><div class="calltoactionbox"><div class="jDialog highlights"><div class="container secondary"><div class="jDialogPrintHide"><p style="text-align:right;margin-bottom:6px;margin-top:4px;"><a class="jOpener" name="afp19980701p139-t2"><strong>View/Print Table</strong></a></p><div class="journalTable"><span class="table-label">TABLE 2</span><h4 class=" table-title&#xA;       ">Medications for Alcohol Detoxification</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Mild withdrawal</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Moderate withdrawal</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Severe withdrawal (delirium tremens)*</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Loading-dose method</span></th></tr></thead><tr><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">Diazepam (Valium), 5 to 10 mg orally as needed<span class="line-break"> </span><span class="italic">or</span><span class="line-break"> </span>Lorazepam (Ativan), 1 to 2 mg orally every 4 to 6 hours as needed for 1 to 3 days</p></td><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">Diazepam:<span class="line-break"> </span>15 to 20 mg orally four times daily on day 1<span class="line-break"> </span>10 to 20 mg orally four times daily on day 2<span class="line-break"> </span>5 to 15 mg orally four times daily on day 3<span class="line-break"> </span>10 mg orally four times daily on day 4<span class="line-break"> </span>5 mg orally four times daily on day 5<span class="line-break"> </span><span class="italic">or</span><span class="line-break"> </span>Lorazepam:<span class="line-break"> </span>2 to 4 mg orally four times daily on days 1 and 2<span class="line-break"> </span>1 to 2 mg orally four times daily on days 3 and 4<span class="line-break"> </span>1 mg orally twice daily on day 5</p></td><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">Diazepam, 10 to 25 mg orally as needed every hour while awake until sedation occurs<span class="line-break"> </span>Lorazepam, 1 to 2 mg intravenously as needed every hour while awake for 3 to 5 days (to sedate)</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Diazepam, 10 mg, or chlordiazepoxide (Librium), 25 mg, orally every hour<span class="line-break"> </span>Diazepam may be given intravenously</p></td></tr></table><table class="&#xA;                          no-mobile-table&#xA;                      "><tr><td valign="top" colspan="3" rowspan="1" align="left"><p class="Tabledata"><span class="italic">Administer medication when:</span></p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Systolic blood pressure: &gt; 150 mm Hg</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Systolic blood pressure: 150 to 200 mm Hg</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Systolic blood pressure: &gt; 200 mm Hg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Diastolic blood pressure: &gt; 90 mm Hg</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Diastolic blood pressure: 100 to 140 mm Hg</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Diastolic blood pressure: &gt; 140 mm Hg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Pulse: &gt; 100</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Pulse: 110 to 140</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Pulse: &gt; 140</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Temperature: &gt; 37.7°C (100°F)</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Temperature: 37.7°C to 38.3°C (100°F to 101°F)</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Temperature: &gt; 38.3°C (101°F)</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Tremulousness, insomnia, agitation are present</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Tremulousness, insomnia, agitation are present</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Tremulousness, insomnia, agitation are present</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn">*&#x2014;<span class="italic">Monitoring in an intensive care unit is recommended for cardiac and respiratory function, fluid and nutrition replacement, vital signs and mental status. Restraints are indicated in patients who are confused or agitated to protect the patient from self and others (delirium tremens can be a terrifying and life-threatening state). Thiamine, 100 mg intramuscularly or orally every day for 3 to 7 days, hydration and magnesium replacement may be indicated, according to the severity of the withdrawal state</span>. <span class="italic"><a class="bibrRef" href="#afp19980701p139-b5">5</a><span>,</span><a class="bibrRef" href="#afp19980701p139-b6">6</a><span>,</span><a class="bibrRef" href="#afp19980701p139-b10">10</a><span>,</span><a class="bibrRef" href="#afp19980701p139-b21">21</a></span></p></div></div></div></div><div class="jModal" title="TABLE 2" name="afp19980701p139-t2"><div class="tableModal"><span class="table-label">TABLE 2</span><h4 class=" table-title&#xA;       ">Medications for Alcohol Detoxification</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Mild withdrawal</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Moderate withdrawal</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Severe withdrawal (delirium tremens)*</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Loading-dose method</span></th></tr></thead><tr><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">Diazepam (Valium), 5 to 10 mg orally as needed<span class="line-break"> </span><span class="italic">or</span><span class="line-break"> </span>Lorazepam (Ativan), 1 to 2 mg orally every 4 to 6 hours as needed for 1 to 3 days</p></td><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">Diazepam:<span class="line-break"> </span>15 to 20 mg orally four times daily on day 1<span class="line-break"> </span>10 to 20 mg orally four times daily on day 2<span class="line-break"> </span>5 to 15 mg orally four times daily on day 3<span class="line-break"> </span>10 mg orally four times daily on day 4<span class="line-break"> </span>5 mg orally four times daily on day 5<span class="line-break"> </span><span class="italic">or</span><span class="line-break"> </span>Lorazepam:<span class="line-break"> </span>2 to 4 mg orally four times daily on days 1 and 2<span class="line-break"> </span>1 to 2 mg orally four times daily on days 3 and 4<span class="line-break"> </span>1 mg orally twice daily on day 5</p></td><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">Diazepam, 10 to 25 mg orally as needed every hour while awake until sedation occurs<span class="line-break"> </span>Lorazepam, 1 to 2 mg intravenously as needed every hour while awake for 3 to 5 days (to sedate)</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Diazepam, 10 mg, or chlordiazepoxide (Librium), 25 mg, orally every hour<span class="line-break"> </span>Diazepam may be given intravenously</p></td></tr></table><table class="&#xA;                          no-mobile-table&#xA;                      "><tr><td valign="top" colspan="3" rowspan="1" align="left"><p class="Tabledata"><span class="italic">Administer medication when:</span></p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Systolic blood pressure: &gt; 150 mm Hg</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Systolic blood pressure: 150 to 200 mm Hg</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Systolic blood pressure: &gt; 200 mm Hg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Diastolic blood pressure: &gt; 90 mm Hg</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Diastolic blood pressure: 100 to 140 mm Hg</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Diastolic blood pressure: &gt; 140 mm Hg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Pulse: &gt; 100</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Pulse: 110 to 140</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Pulse: &gt; 140</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Temperature: &gt; 37.7°C (100°F)</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Temperature: 37.7°C to 38.3°C (100°F to 101°F)</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Temperature: &gt; 38.3°C (101°F)</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Tremulousness, insomnia, agitation are present</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Tremulousness, insomnia, agitation are present</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Tremulousness, insomnia, agitation are present</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn">*&#x2014;<span class="italic">Monitoring in an intensive care unit is recommended for cardiac and respiratory function, fluid and nutrition replacement, vital signs and mental status. Restraints are indicated in patients who are confused or agitated to protect the patient from self and others (delirium tremens can be a terrifying and life-threatening state). Thiamine, 100 mg intramuscularly or orally every day for 3 to 7 days, hydration and magnesium replacement may be indicated, according to the severity of the withdrawal state</span>. <span class="italic"><a class="bibrRef" href="#afp19980701p139-b5">5</a><span>,</span><a class="bibrRef" href="#afp19980701p139-b6">6</a><span>,</span><a class="bibrRef" href="#afp19980701p139-b10">10</a><span>,</span><a class="bibrRef" href="#afp19980701p139-b21">21</a></span></p></div></div></div></div></div></div></div></div></div><div class="jSection" id="sec-2"><h2>Benzodiazepines and Other Sedative/Hypnotics</h2><div class="mjToggle noPrint"><div class="mjHeader noPrint"><span style="margin:5px;" class="mobileSectionLink">Jump to section +</span></div><div class="mjContent noPrint"><ul><li><a href="#abstract" alt="Abstract">
                                    Abstract
                                </a></li><li><a href="#sec-1">Pharmacotherapy for Withdrawal Syndromes</a></li><li><a href="#sec-2">Benzodiazepines and Other Sedative/Hypnotics</a></li><li><a href="#sec-3">Stimulants (Cocaine, Amphetamines and Derivatives)</a></li><li><a href="#sec-4">Phencyclidine and Other Psychedelic Agents</a></li><li><a href="#sec-5">Medications for Relapse Prevention</a></li><li><a href="#sec-6">Use of Psychosocial Addiction Treatment to Prevent Relapse</a></li><li><a href="#ref-list-1">References</a></li></ul></div></div><p>The signs and symptoms of benzodiazepine withdrawal are similar to those for withdrawal of other sedative/hypnotics (barbiturates, ethchylorvynol [Placidyl], glutethimide and meprobamate [Equanil]) <span class="italic">(<a href="#afp19980701p139-t1">Table 1</a>)</span>. The management of withdrawal for sedative/hypnotics (barbiturates) is similar to that for benzodiazepines <span class="italic">(<a href="#afp19980701p139-t3">Table 3</a>)</span>.</p><div class="table-format" id="afp19980701p139-t3"><div class="calltoactionbox"><div class="jDialog highlights"><div class="container secondary"><div class="jDialogPrintHide"><p style="text-align:right;margin-bottom:6px;margin-top:4px;"><a class="jOpener" name="afp19980701p139-t3"><strong>View/Print Table</strong></a></p><div class="journalTable"><span class="table-label">TABLE 3</span><h4 class=" table-title&#xA;       ">Benzodiazepine (Barbiturate) Withdrawal</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Short-acting detoxification</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Long-acting detoxification</span></th></tr></thead><tr><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">7- to 10-day taper:</p></td><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">10- to 14-day taper:</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">On day 1, give diazepam (Valium), 10 to 20 mg orally four times daily, and taper until the dosage is 5 to 10 mg orally on last day. Avoid giving the drug &#x201c;as needed.&#x201d; Adjustments in dosage according to the patient's clinical state may be indicated.</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">On day 1, give diazepam, 10 to 20 mg orally four times daily, and taper until the dosage is 5 to 10 mg orally on last day. Avoid giving the drug &#x201c;as needed&#x201d;. Adjustments in dosage according to the patient's clinical state may be indicated.</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"><span class="italic">or</span></p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"><span class="italic">or</span></p></td></tr><tr><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">7- to 10-day taper:</p></td><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">10- to 14-day taper:</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Calculate barbiturate or benzodiazepine equivalence and give 50 percent of the original dosage; taper (if actual dosage is known before detoxification). Avoid giving the drug &#x201c;as needed.&#x201d;</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Calculate barbiturate or benzodiazepine equivalence and give 50 percent of the original dosage; taper (if actual dosage is known before detoxification). Avoid giving the drug &#x201c;as needed.&#x201d;</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">Information from references <a class="bibrRef" href="#afp19980701p139-b5">5</a> through <a class="bibrRef" href="#afp19980701p139-b8">8</a></span>.</p></div></div></div></div><div class="jModal" title="TABLE 3" name="afp19980701p139-t3"><div class="tableModal"><span class="table-label">TABLE 3</span><h4 class=" table-title&#xA;       ">Benzodiazepine (Barbiturate) Withdrawal</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Short-acting detoxification</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Long-acting detoxification</span></th></tr></thead><tr><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">7- to 10-day taper:</p></td><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">10- to 14-day taper:</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">On day 1, give diazepam (Valium), 10 to 20 mg orally four times daily, and taper until the dosage is 5 to 10 mg orally on last day. Avoid giving the drug &#x201c;as needed.&#x201d; Adjustments in dosage according to the patient's clinical state may be indicated.</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">On day 1, give diazepam, 10 to 20 mg orally four times daily, and taper until the dosage is 5 to 10 mg orally on last day. Avoid giving the drug &#x201c;as needed&#x201d;. Adjustments in dosage according to the patient's clinical state may be indicated.</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"><span class="italic">or</span></p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"><span class="italic">or</span></p></td></tr><tr><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">7- to 10-day taper:</p></td><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">10- to 14-day taper:</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Calculate barbiturate or benzodiazepine equivalence and give 50 percent of the original dosage; taper (if actual dosage is known before detoxification). Avoid giving the drug &#x201c;as needed.&#x201d;</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Calculate barbiturate or benzodiazepine equivalence and give 50 percent of the original dosage; taper (if actual dosage is known before detoxification). Avoid giving the drug &#x201c;as needed.&#x201d;</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">Information from references <a class="bibrRef" href="#afp19980701p139-b5">5</a> through <a class="bibrRef" href="#afp19980701p139-b8">8</a></span>.</p></div></div></div></div></div></div></div></div><p>Withdrawal from benzodiazepines is not usually marked by significant elevations in blood pressure and pulse as commonly occur in patients undergoing alcohol withdrawal. Furthermore, supplemental doses of sedatives taken as needed are usually not required for changes in vital signs<a class="superscript bibrRef" href="#afp19980701p139-b5">5</a><span class="superscript">&#x2013;</span><a class="superscript bibrRef" href="#afp19980701p139-b8">8</a>  <span class="italic">(<a href="#afp19980701p139-t3">Table 3</a>)</span>. Since benzodiazepines have cross-tolerance within that drug class as well as with other sedative/hypnotic drugs, benzodiazepines can be substituted for other sedative/hypnotics and vice versa. Equivalent doses can be calculated if the actual doses are known before beginning the tapering process <span class="italic">(<a href="#afp19980701p139-t4">Table 4</a>)</span>.</p><div class="table-format" id="afp19980701p139-t4"><div class="calltoactionbox"><div class="jDialog highlights"><div class="container secondary"><div class="jDialogPrintHide"><p style="text-align:right;margin-bottom:6px;margin-top:4px;"><a class="jOpener" name="afp19980701p139-t4"><strong>View/Print Table</strong></a></p><div class="journalTable"><span class="table-label">TABLE 4</span><h4 class=" table-title&#xA;       ">Drug Dose Conversion* (Equivalent to 60 mg of Diazepam [Valium] and 180 mg of Phenobarbital)</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Drug</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Dose (mg)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Diazepam (60 mg) conversion factor</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Phenobarbital (180 mg) conversion factor</span></th></tr></thead><tr><td valign="top" colspan="5" rowspan="1" align="left"><p class="Tabledata">Benzodiazepines</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Alprazolam (Xanax)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">6</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">10.0</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">30.0</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Chlordiazepoxide (Librium) [
<a class="object" id="afp19980801p139-c1" href="https://www.aafp.org/afp/1998/0915/p866a.html">corrected</a>]</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">150</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.4</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1.2</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Clonazepam (Klonopin)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">24</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">2.5</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">7.5</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Flurazepam (Dalmane)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">90</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.6</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">2.0</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Halazepam (Paxipam)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">240</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.25</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.75</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Lorazepam (Ativan)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">12</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">5.0</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">15.0</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Oxazepam (Serax)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">60</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1.0</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">3.0</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Temazepam (Restoril)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">60</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1.0</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">3.0</p></td></tr><tr><td valign="top" colspan="5" rowspan="1" align="left"><p class="Tabledata">Barbiturates</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Butabarbital (Butisol)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">600</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.1</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.3</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Pentobarbital (Nembutal)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">600</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.1</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.3</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Secobarbital (Seconal)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">600</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.1</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.3</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Phenobarbital</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">180</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.33</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1.0</p></td></tr><tr><td valign="top" colspan="5" rowspan="1" align="left"><p class="Tabledata">Glycerol</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Meprobamate (Equanil)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">2,400</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.025</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.075</p></td></tr><tr><td valign="top" colspan="5" rowspan="1" align="left"><p class="Tabledata">Piperideinedione</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Glutethimide (Doriden)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1,500</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.04</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.12</p></td></tr><tr><td valign="top" colspan="5" rowspan="1" align="left"><p class="Tabledata">Quinazoline</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Methaqualone</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1,800</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.03</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.1</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">NOTE: To find the dose of chlordiazepoxide equivalent to that of diazepam, multiply by 0.4. A dose of 150 mg of chlordiazepoxide is equivalent to a dose of 60 mg of diazepam. A dose of 100 mg is equivalent to a dose of 40 mg, etc</span>.</p></div><div class="fn"><p class="fn">*&#x2014;<span class="italic">Conversion factor × dose = diazepam or phenobarbital dose equivalent. Divide this amount in half to determine starting dosage</span>.</p></div></div></div></div><div class="jModal" title="TABLE 4" name="afp19980701p139-t4"><div class="tableModal"><span class="table-label">TABLE 4</span><h4 class=" table-title&#xA;       ">Drug Dose Conversion* (Equivalent to 60 mg of Diazepam [Valium] and 180 mg of Phenobarbital)</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Drug</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Dose (mg)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Diazepam (60 mg) conversion factor</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Phenobarbital (180 mg) conversion factor</span></th></tr></thead><tr><td valign="top" colspan="5" rowspan="1" align="left"><p class="Tabledata">Benzodiazepines</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Alprazolam (Xanax)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">6</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">10.0</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">30.0</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Chlordiazepoxide (Librium) [
<a class="object" id="afp19980801p139-c1" href="https://www.aafp.org/afp/1998/0915/p866a.html">corrected</a>]</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">150</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.4</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1.2</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Clonazepam (Klonopin)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">24</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">2.5</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">7.5</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Flurazepam (Dalmane)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">90</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.6</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">2.0</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Halazepam (Paxipam)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">240</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.25</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.75</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Lorazepam (Ativan)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">12</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">5.0</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">15.0</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Oxazepam (Serax)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">60</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1.0</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">3.0</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Temazepam (Restoril)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">60</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1.0</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">3.0</p></td></tr><tr><td valign="top" colspan="5" rowspan="1" align="left"><p class="Tabledata">Barbiturates</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Butabarbital (Butisol)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">600</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.1</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.3</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Pentobarbital (Nembutal)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">600</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.1</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.3</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Secobarbital (Seconal)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">600</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.1</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.3</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Phenobarbital</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">180</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.33</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1.0</p></td></tr><tr><td valign="top" colspan="5" rowspan="1" align="left"><p class="Tabledata">Glycerol</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Meprobamate (Equanil)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">2,400</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.025</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.075</p></td></tr><tr><td valign="top" colspan="5" rowspan="1" align="left"><p class="Tabledata">Piperideinedione</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Glutethimide (Doriden)</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1,500</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.04</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.12</p></td></tr><tr><td valign="top" colspan="5" rowspan="1" align="left"><p class="Tabledata">Quinazoline</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Methaqualone</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1,800</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.03</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">0.1</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">NOTE: To find the dose of chlordiazepoxide equivalent to that of diazepam, multiply by 0.4. A dose of 150 mg of chlordiazepoxide is equivalent to a dose of 60 mg of diazepam. A dose of 100 mg is equivalent to a dose of 40 mg, etc</span>.</p></div><div class="fn"><p class="fn">*&#x2014;<span class="italic">Conversion factor × dose = diazepam or phenobarbital dose equivalent. Divide this amount in half to determine starting dosage</span>.</p></div></div></div></div></div></div></div></div><p>A long-acting benzodiazepine is more effective than short-acting preparations in suppressing withdrawal symptoms and in producing a gradual and smooth transition to the abstinent state. In general, greater patient compliance and lower morbidity can be expected with the use of the longer-acting benzodiazepines, since withdrawal symptoms are less intense.</p><p>A taper over eight to 12 weeks or longer may be indicated in patients who have been taking benzodiazepines for several years <span class="italic">(<a href="#afp19980701p139-t5">Table 5</a>)</span>. The rate of taper can be adjusted according to patient tolerance. The rate of taper is a reduction in dosage of approximately 25 percent per quarter of the withdrawal period (e.g., 25 percent per week for one month).</p><div class="table-format" id="afp19980701p139-t5"><div class="calltoactionbox"><div class="jDialog highlights"><div class="container secondary"><div class="jDialogPrintHide"><p style="text-align:right;margin-bottom:6px;margin-top:4px;"><a class="jOpener" name="afp19980701p139-t5"><strong>View/Print Table</strong></a></p><div class="journalTable"><span class="table-label">TABLE 5</span><h4 class=" table-title&#xA;       ">Benzodiazepine Taper</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Day</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Dosage per day (mg)</span></th></tr></thead><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">10 mg three times daily = 30 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">2</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">10 mg three times daily = 30 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">3</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">10 mg three times daily = 30 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">4</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg four times daily = 20 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">5</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg four times daily = 20 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">6</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg four times daily = 20 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">7</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg three times daily = 15 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">8</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg three times daily = 15 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">9</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg three times daily = 15 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">10</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg twice daily = 10 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">11</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg twice daily = 10 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">12</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg twice daily = 10 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">13</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg every day = 5 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">14</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg every day = 5 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">15</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg every day = 5 mg</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">Example: Patient taking 12 mg of lorazepam (Ativan) per day = 60 mg diazepam (Valium) ×(50 percent reduction) = 30 mg</span>.</p></div></div></div></div><div class="jModal" title="TABLE 5" name="afp19980701p139-t5"><div class="tableModal"><span class="table-label">TABLE 5</span><h4 class=" table-title&#xA;       ">Benzodiazepine Taper</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Day</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Dosage per day (mg)</span></th></tr></thead><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">10 mg three times daily = 30 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">2</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">10 mg three times daily = 30 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">3</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">10 mg three times daily = 30 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">4</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg four times daily = 20 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">5</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg four times daily = 20 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">6</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg four times daily = 20 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">7</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg three times daily = 15 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">8</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg three times daily = 15 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">9</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg three times daily = 15 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">10</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg twice daily = 10 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">11</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg twice daily = 10 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">12</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg twice daily = 10 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">13</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg every day = 5 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">14</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg every day = 5 mg</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">15</p></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">5 mg every day = 5 mg</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">Example: Patient taking 12 mg of lorazepam (Ativan) per day = 60 mg diazepam (Valium) ×(50 percent reduction) = 30 mg</span>.</p></div></div></div></div></div></div></div></div></div><div class="jSection" id="sec-3"><h2>Stimulants (Cocaine, Amphetamines and Derivatives)</h2><div class="mjToggle noPrint"><div class="mjHeader noPrint"><span style="margin:5px;" class="mobileSectionLink">Jump to section +</span></div><div class="mjContent noPrint"><ul><li><a href="#abstract" alt="Abstract">
                                    Abstract
                                </a></li><li><a href="#sec-1">Pharmacotherapy for Withdrawal Syndromes</a></li><li><a href="#sec-2">Benzodiazepines and Other Sedative/Hypnotics</a></li><li><a href="#sec-3">Stimulants (Cocaine, Amphetamines and Derivatives)</a></li><li><a href="#sec-4">Phencyclidine and Other Psychedelic Agents</a></li><li><a href="#sec-5">Medications for Relapse Prevention</a></li><li><a href="#sec-6">Use of Psychosocial Addiction Treatment to Prevent Relapse</a></li><li><a href="#ref-list-1">References</a></li></ul></div></div><p>Supportive rather than specific treatment is indicated in patients who are undergoing withdrawal from stimulants. Observation and monitoring for depression and suicidal ideation are advised <span class="italic">(<a href="#afp19980701p139-t1">Table 1</a>)</span>. Since stimulant withdrawal may cause significant irritability, a dosage of 5 to 10 mg of diazepam given orally every six hours on a fixed schedule or as needed for two to three days is recommended in patients with mild to moderate withdrawal symptoms. For severe withdrawal symptoms with persistent depression, therapy may be initiated with antidepressants such as desipramine (Norpramin), at a dosage of 50 mg per day, titrated upward every other day in 50-mg increments until a dosage of 150 to 250 mg per day is attained. The dosage is maintained for three to six months and discontinued by gradually tapering the drug over two weeks.<a class="superscript bibrRef" href="#afp19980701p139-b4">4</a><span class="superscript">,</span><a class="superscript bibrRef" href="#afp19980701p139-b9">9</a> However, desipramine is not recommended routinely for management of withdrawal.</p><h3>Opiates</h3><p>Withdrawal symptoms from heroin addiction are predictable and identifiable <span class="italic">(<a href="#afp19980701p139-t1">Table 1</a>)</span>. Management of withdrawal can be accomplished with clonidine (Catapres) or methadone. Patients for whom clonidine is indicated include intranasal heroin users, outpatients and those who are motivated to achieve abstinency. Patients for whom methadone is indicated include intravenous users, inpatients, those who have medical and psychiatric complications and patients with a history of poor compliance when withdrawing from opiates<a class="superscript bibrRef" href="#afp19980701p139-b5">5</a><span class="superscript">,</span><a class="superscript bibrRef" href="#afp19980701p139-b9">9</a><span class="superscript">,</span><a class="superscript bibrRef" href="#afp19980701p139-b10">10</a>  <span class="italic">(<a href="#afp19980701p139-t6">Table 6</a>)</span>. Federal regulations do not allow the use of methadone for detoxification if opiate withdrawal is the primary diagnosis. However, methadone may be used if the primary diagnosis is a medical condition and the secondary condition is withdrawal from opiates.</p><div class="table-format" id="afp19980701p139-t6"><div class="calltoactionbox"><div class="jDialog highlights"><div class="container secondary"><div class="jDialogPrintHide"><p style="text-align:right;margin-bottom:6px;margin-top:4px;"><a class="jOpener" name="afp19980701p139-t6"><strong>View/Print Table</strong></a></p><div class="journalTable"><span class="table-label">TABLE 6</span><h4 class=" table-title&#xA;       ">Opiate Detoxification (Heroin/Morphine Withdrawal)</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Clonidine (Catapres) substitution</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Methadone substitution</span></th></tr></thead><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Clonidine, 0.1 or 0.2 mg orally, given every 4 to 6 hours as needed for signs and symptoms of withdrawal for 5 to 7 days. (Peak dosages are given between 2 and 4 days.) Check blood pressure before each dose and do not give medication if patient is hypotensive.</p></td><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">Methadone test dose of 10 mg given orally in liquid or crushed tablet. Additional 10- to 20-mg doses are given for signs and symptoms of withdrawal every 4 to 6 hours for 24 hours after initial dose. Range for daily dose is 15 to 30 mg in 24 hours. Repeat total first day dose in a single dose or two divided doses (stabilization dose) for 2 to 3 days, then reduce dosage by 5 to 10 mg per day until medication is completely withdrawn. Methadone cannot be given for detoxification from other opiates unless licensed by the federal government or a medical comorbidity is the condition of primary treatment.</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">Information from references <a class="bibrRef" href="#afp19980701p139-b5">5</a><span>, </span><a class="bibrRef" href="#afp19980701p139-b9">9</a> and <a class="bibrRef" href="#afp19980701p139-b10">10</a></span>.</p></div></div></div></div><div class="jModal" title="TABLE 6" name="afp19980701p139-t6"><div class="tableModal"><span class="table-label">TABLE 6</span><h4 class=" table-title&#xA;       ">Opiate Detoxification (Heroin/Morphine Withdrawal)</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Clonidine (Catapres) substitution</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Methadone substitution</span></th></tr></thead><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Clonidine, 0.1 or 0.2 mg orally, given every 4 to 6 hours as needed for signs and symptoms of withdrawal for 5 to 7 days. (Peak dosages are given between 2 and 4 days.) Check blood pressure before each dose and do not give medication if patient is hypotensive.</p></td><td valign="top" colspan="2" rowspan="1" align="left"><p class="Tabledata">Methadone test dose of 10 mg given orally in liquid or crushed tablet. Additional 10- to 20-mg doses are given for signs and symptoms of withdrawal every 4 to 6 hours for 24 hours after initial dose. Range for daily dose is 15 to 30 mg in 24 hours. Repeat total first day dose in a single dose or two divided doses (stabilization dose) for 2 to 3 days, then reduce dosage by 5 to 10 mg per day until medication is completely withdrawn. Methadone cannot be given for detoxification from other opiates unless licensed by the federal government or a medical comorbidity is the condition of primary treatment.</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">Information from references <a class="bibrRef" href="#afp19980701p139-b5">5</a><span>, </span><a class="bibrRef" href="#afp19980701p139-b9">9</a> and <a class="bibrRef" href="#afp19980701p139-b10">10</a></span>.</p></div></div></div></div></div></div></div></div></div><div class="jSection" id="sec-4"><h2>Phencyclidine and Other Psychedelic Agents</h2><div class="mjToggle noPrint"><div class="mjHeader noPrint"><span style="margin:5px;" class="mobileSectionLink">Jump to section +</span></div><div class="mjContent noPrint"><ul><li><a href="#abstract" alt="Abstract">
                                    Abstract
                                </a></li><li><a href="#sec-1">Pharmacotherapy for Withdrawal Syndromes</a></li><li><a href="#sec-2">Benzodiazepines and Other Sedative/Hypnotics</a></li><li><a href="#sec-3">Stimulants (Cocaine, Amphetamines and Derivatives)</a></li><li><a href="#sec-4">Phencyclidine and Other Psychedelic Agents</a></li><li><a href="#sec-5">Medications for Relapse Prevention</a></li><li><a href="#sec-6">Use of Psychosocial Addiction Treatment to Prevent Relapse</a></li><li><a href="#ref-list-1">References</a></li></ul></div></div><p>Acute symptoms of withdrawal from psychedelic agents may be diminished or reversed by using therapy with haloperidol (Haldol), 5 to 10 mg intramuscularly or orally every three to six hours as tolerated and needed for behavior control. Lorazepam, 1 to 2 mg intravenously, or diazepam, 5 to 10 mg orally every three to six hours, can also be given as needed. Behavior control may also be indicated (e.g., isolation and restraints).<a class="superscript bibrRef" href="#afp19980701p139-b5">5</a><span class="superscript">,</span><a class="superscript bibrRef" href="#afp19980701p139-b9">9</a><span class="superscript">,</span><a class="superscript bibrRef" href="#afp19980701p139-b11">11</a></p></div><div class="jSection" id="sec-5"><h2>Medications for Relapse Prevention</h2><div class="mjToggle noPrint"><div class="mjHeader noPrint"><span style="margin:5px;" class="mobileSectionLink">Jump to section +</span></div><div class="mjContent noPrint"><ul><li><a href="#abstract" alt="Abstract">
                                    Abstract
                                </a></li><li><a href="#sec-1">Pharmacotherapy for Withdrawal Syndromes</a></li><li><a href="#sec-2">Benzodiazepines and Other Sedative/Hypnotics</a></li><li><a href="#sec-3">Stimulants (Cocaine, Amphetamines and Derivatives)</a></li><li><a href="#sec-4">Phencyclidine and Other Psychedelic Agents</a></li><li><a href="#sec-5">Medications for Relapse Prevention</a></li><li><a href="#sec-6">Use of Psychosocial Addiction Treatment to Prevent Relapse</a></li><li><a href="#ref-list-1">References</a></li></ul></div></div><h3>Disulfiram</h3><p>Disulfiram is a major aversive agent. It has been shown in a randomized, double-blind, placebo-controlled multisite trial<a class="superscript bibrRef" href="#afp19980701p139-b12">12</a> to be effective as an adjunct to other forms of addiction treatment.</p><p>The key components to effective use of disulfiram are overall patient motivation for abstinence and expectation of adverse reactions. Selected patients who have a commitment to working with other treatments for alcoholism may benefit from the addition of disulfiram therapy. The usual dosage of disulfiram is 250 mg per day, or 125 mg per day in patients who experience side effects such as sedation, sexual dysfunction and elevated liver enzymes.<a class="superscript bibrRef" href="#afp19980701p139-b12">12</a><span class="superscript">,</span><a class="superscript bibrRef" href="#afp19980701p139-b13">13</a></p><p>Disulfiram inhibits acetaldehyde dehydrogenase, an enzyme that catalyzes the degradation of acetaldehyde (formed by the action of alcohol dehydrogenase on alcohol). An accumulation of acetaldehyde produces an unpleasant reaction when alcohol is consumed that is similar to a severe hangover. It is potentially lethal, although only a small number of fatalities have been reported. The reaction to disulfiram is characterized by headache, diaphoresis, tachycardia, nausea and vomiting, cardiovascular collapse, delirium, seizures and, occasionally, death. Before using disulfiram, patients must have a blood alcohol level of zero and must be able to comprehend the risks and benefits of treatment.<a class="superscript bibrRef" href="#afp19980701p139-b12">12</a><span class="superscript">,</span><a class="superscript bibrRef" href="#afp19980701p139-b13">13</a></p><h3>Methadone</h3><p>Methadone maintenance is a form of pharmacologic management of opiate addiction. Methadone maintenance is performed in programs that are in compliance with federal regulations. Patients must meet admission requirements and must conform to clinic standards to participate in the program. Typically, methadone is given daily in oral doses ranging from 30 to 100 mg or greater. Methadone is administered under the supervision of a physician. Studies of methadone maintenance show initial efficacy following entrance to the program, and the medication remains effective in conjunction with other psychosocial forms of addiction treatment. Moreover, some studies show a reduction in intravenous drug use as well as in the rate of tests positive for human immunodeficiency virus infection.<a class="superscript bibrRef" href="#afp19980701p139-b5">5</a><span class="superscript">,</span><a class="superscript bibrRef" href="#afp19980701p139-b9">9</a><span class="superscript">,</span><a class="superscript bibrRef" href="#afp19980701p139-b14">14</a> Methadone is an opiate agonist that acts competitively at opiate receptor sites to produce effects similar to those of other forms of opioids, such as heroin. Methadone is itself addicting, and patients commonly relapse to use of other drugs such as cocaine, alcohol, benzodiazepines and heroin. Nonetheless, methadone maintenance can be an alternative for patients who are addicted to intravenous heroin, particularly those who cannot or will not accept an abstinence-based addiction treatment program.<a class="superscript bibrRef" href="#afp19980701p139-b5">5</a><span class="superscript">,</span><a class="superscript bibrRef" href="#afp19980701p139-b9">9</a><span class="superscript">,</span><a class="superscript bibrRef" href="#afp19980701p139-b14">14</a></p><h3>Naltrexone</h3><p>Naltrexone (ReVia) is an opioid antagonist that acts at opiate receptors to competitively inhibit effects of opiate agonists. It has no analgesic activity of its own. Preliminary controlled double-blind studies suggest that naltrexone is effective in decreasing the mean number of drinking days per relapse and in reducing the subjective craving for alcohol. Study subjects who relapsed tended to drink less alcohol and had shorter relapse periods than control subjects. Naltrexone was considered to be an adjunctive treatment, since all study subjects also were undergoing psychosocial forms of treatment for alcoholism.<a class="superscript bibrRef" href="#afp19980701p139-b15">15</a><span class="superscript">&#x2013;</span><a class="superscript bibrRef" href="#afp19980701p139-b17">17</a></p><p>While interest in developing these agents appears warranted, caution is urged because of disappointment in the clinical efficacy of naltrexone in previous studies of patients addicted to opiates (except those who are most highly motivated).</p></div><div class="jSection" id="sec-6"><h2>Use of Psychosocial Addiction Treatment to Prevent Relapse</h2><div class="mjToggle noPrint"><div class="mjHeader noPrint"><span style="margin:5px;" class="mobileSectionLink">Jump to section +</span></div><div class="mjContent noPrint"><ul><li><a href="#abstract" alt="Abstract">
                                    Abstract
                                </a></li><li><a href="#sec-1">Pharmacotherapy for Withdrawal Syndromes</a></li><li><a href="#sec-2">Benzodiazepines and Other Sedative/Hypnotics</a></li><li><a href="#sec-3">Stimulants (Cocaine, Amphetamines and Derivatives)</a></li><li><a href="#sec-4">Phencyclidine and Other Psychedelic Agents</a></li><li><a href="#sec-5">Medications for Relapse Prevention</a></li><li><a href="#sec-6">Use of Psychosocial Addiction Treatment to Prevent Relapse</a></li><li><a href="#ref-list-1">References</a></li></ul></div></div><p>Medical management of alcohol and drug withdrawal often is not sufficient to produce sustained abstinence from recurrent use. Therefore, other types of addiction treatment are indicated to prevent relapse to alcohol and drug use following treatment of withdrawal.<a class="superscript bibrRef" href="#afp19980701p139-b18">18</a></p><h3>Cost Benefits of Treatment</h3><p>Historically, addiction treatment has not been integrated within the mainstream of the health care system, even though such treatment is effective and reduces health care costs. More accurate data on treatment outcomes and costs are needed so that informed and rational decisions about addiction treatment can be formulated by consumers, insurers, physicians and policy makers. Fortunately, the results of several recent health services research studies unequivocally demonstrate the cost effectiveness of addiction treatment.<a class="superscript bibrRef" href="#afp19980701p139-b19">19</a><span class="superscript">&#x2013;</span><a class="superscript bibrRef" href="#afp19980701p139-b22">22</a></p><h3>Treatment Approaches and Effectiveness</h3><p>The abstinence-based method is commonly used to treat alcohol/drug addiction (95 percent of programs surveyed). This method utilizes cognitive behavior techniques and referral to 12-step recovery programs, such as Alcoholics Anonymous (AA) and Narcotics Anonymous (NA).<a class="superscript bibrRef" href="#afp19980701p139-b23">23</a></p><p>One-year abstinence rates of 80 to 90 percent were achieved when patients participated in weekly continuing care and/or AA meetings after discharge from the treatment program <span class="italic">(<a href="#afp19980701p139-t7">Table 7</a>)</span>. Also, one-year abstinence rates were associated with reduced rates of medical and psychiatric utilization<a class="superscript bibrRef" href="#afp19980701p139-b18">18</a>  <span class="italic">(<a href="#afp19980701p139-t8">Table 8</a>)</span>.</p><div class="table-format" id="afp19980701p139-t7"><div class="calltoactionbox"><div class="jDialog highlights"><div class="container secondary"><div class="jDialogPrintHide"><p style="text-align:right;margin-bottom:6px;margin-top:4px;"><a class="jOpener" name="afp19980701p139-t7"><strong>View/Print Table</strong></a></p><div class="journalTable"><span class="table-label">TABLE 7</span><h4 class=" table-title&#xA;       ">One-Year Abstinence by Continuum of Care and Self-Help Support</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="2" rowspan="2" align="left"><span class="italic">Care criteria</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Inpatients (N = 6,508)</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Outpatients (N = 1,572)</span></th></tr><tr><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Attending (%)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Abstinent (%)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Attending (%)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Abstinent (%)</span></th></tr></thead><tr><td valign="top" colspan="6" rowspan="1" align="left"><p class="Tabledata">Months of continuing care attended in one year</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">0</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">42</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">53</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">34</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">48</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">1 to 5</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">32</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">55</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">33</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">61</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">6 to 11</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">19</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">71</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">18</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">68</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">12</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">8</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">88</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">14</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">89</p></td></tr><tr><td valign="top" colspan="6" rowspan="1" align="left"><p class="Tabledata">AA attendance</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Non-attender</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">54</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">47</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">43</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">49</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Regular attender</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">46</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">74</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">57</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">80</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">AA = Alcoholics Anonymous</span>.</p></div><div class="fn"><p class="fn"><span class="italic">Information from reference <a class="bibrRef" href="#afp19980701p139-b23">23</a></span>.</p></div></div></div></div><div class="jModal" title="TABLE 7" name="afp19980701p139-t7"><div class="tableModal"><span class="table-label">TABLE 7</span><h4 class=" table-title&#xA;       ">One-Year Abstinence by Continuum of Care and Self-Help Support</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="2" rowspan="2" align="left"><span class="italic">Care criteria</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Inpatients (N = 6,508)</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Outpatients (N = 1,572)</span></th></tr><tr><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Attending (%)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Abstinent (%)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Attending (%)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Abstinent (%)</span></th></tr></thead><tr><td valign="top" colspan="6" rowspan="1" align="left"><p class="Tabledata">Months of continuing care attended in one year</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">0</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">42</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">53</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">34</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">48</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">1 to 5</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">32</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">55</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">33</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">61</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">6 to 11</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">19</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">71</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">18</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">68</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">12</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">8</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">88</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">14</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">89</p></td></tr><tr><td valign="top" colspan="6" rowspan="1" align="left"><p class="Tabledata">AA attendance</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Non-attender</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">54</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">47</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">43</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">49</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Regular attender</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">46</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">74</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">57</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">80</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">AA = Alcoholics Anonymous</span>.</p></div><div class="fn"><p class="fn"><span class="italic">Information from reference <a class="bibrRef" href="#afp19980701p139-b23">23</a></span>.</p></div></div></div></div></div></div></div></div><div class="table-format" id="afp19980701p139-t8"><div class="calltoactionbox"><div class="jDialog highlights"><div class="container secondary"><div class="jDialogPrintHide"><p style="text-align:right;margin-bottom:6px;margin-top:4px;"><a class="jOpener" name="afp19980701p139-t8"><strong>View/Print Table</strong></a></p><div class="journalTable"><span class="table-label">TABLE 8</span><h4 class=" table-title&#xA;       ">Medical Care Utilization One Year Before and After Treatment</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="2" rowspan="2" align="left"><span class="italic">Care criteria</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Inpatients (N = 6,508)</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Outpatients (N = 1,572)</span></th></tr><tr><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Attending (%)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Abstinent (%)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Attending (%)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Abstinent (%)</span></th></tr></thead><tr><td valign="top" colspan="6" rowspan="1" align="left"><p class="Tabledata">Hospitalizations</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Medical</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">23</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">10</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">16</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">7</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Psychiatric</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">5</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">2</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">4</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Detoxification</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">16</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">4</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">9</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">2</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Any admission</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">28</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">14</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">21</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">9</p></td></tr><tr><td valign="top" colspan="6" rowspan="1" align="left"><p class="Tabledata">Emergency department use</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Medical</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">31</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">22</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">29</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">22</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Psychiatric</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">3</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">3</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Any emergency department use</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">30</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">24</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">29</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">23</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">Information from references <a class="bibrRef" href="#afp19980701p139-b18">18</a> and <a class="bibrRef" href="#afp19980701p139-b23">23</a></span>.</p></div></div></div></div><div class="jModal" title="TABLE 8" name="afp19980701p139-t8"><div class="tableModal"><span class="table-label">TABLE 8</span><h4 class=" table-title&#xA;       ">Medical Care Utilization One Year Before and After Treatment</h4><table class="&#xA;                          no-mobile-table&#xA;                      "><thead><tr><th valign="bottom" class="th" colspan="2" rowspan="2" align="left"><span class="italic">Care criteria</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Inpatients (N = 6,508)</span></th><th valign="bottom" class="th" colspan="2" rowspan="1" align="left"><span class="italic">Outpatients (N = 1,572)</span></th></tr><tr><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Attending (%)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Abstinent (%)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Attending (%)</span></th><th valign="bottom" class="th" colspan="1" rowspan="1" align="left"><span class="italic">Abstinent (%)</span></th></tr></thead><tr><td valign="top" colspan="6" rowspan="1" align="left"><p class="Tabledata">Hospitalizations</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Medical</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">23</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">10</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">16</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">7</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Psychiatric</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">5</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">2</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">4</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Detoxification</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">16</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">4</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">9</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">2</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Any admission</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">28</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">14</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">21</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">9</p></td></tr><tr><td valign="top" colspan="6" rowspan="1" align="left"><p class="Tabledata">Emergency department use</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Medical</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">31</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">22</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">29</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">22</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Psychiatric</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">3</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">3</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">1</p></td></tr><tr><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata"/></td><td valign="top" colspan="1" rowspan="1" align="left"><p class="Tabledata">Any emergency department use</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">30</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">24</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">29</p></td><td valign="top" colspan="1" rowspan="1" align="right"><p class="Tabledata">23</p></td></tr></table><hr class="table-foot"/><div class="table-foot"><div class="fn"><p class="fn"><span class="italic">Information from references <a class="bibrRef" href="#afp19980701p139-b18">18</a> and <a class="bibrRef" href="#afp19980701p139-b23">23</a></span>.</p></div></div></div></div></div></div></div></div><h3>Recovery in Alcoholics Anonymous</h3><p>According to results of a 1992 survey conducted by AA, the following recovery rates were achieved. (1) Of those members sober in AA less than one year, 41 percent will attend AA another year. (2) Of those members sober more than one year and less than five years, 83 percent will attend AA another year. (3) Of those members sober five years or more, 91 percent will attend AA another year.<a class="superscript bibrRef" href="#afp19980701p139-b23">23</a></p><p>Attendance in an abstinence-based treatment program such as AA can increase recovery rates from 41 to 80 percent in patients with alcoholism.<a class="superscript bibrRef" href="#afp19980701p139-b18">18</a><span class="superscript">,</span><a class="superscript bibrRef" href="#afp19980701p139-b23">23</a> For this reason, patients with alcoholism should be referred to AA following withdrawal treatment and during maintenance therapy.</p></div></div></div><script xmlns:xlink="http://www.w3.org/1999/xlink">
     
          $( document ).ready(function() {
if (metaRestrict == 'false'){

$(".pdfLink").css("display","inline");
}


if (typeof cmeExpired !== 'undefined' && cmeExpired == 'false') {
$(".series-text.CME").css("display","block");}

          if (metaRestrict != 'false')
          {

 
          if (accTyp == 'DENIED')
          {              
          $(".journalPreviewLogin, #gradientContainer").css("display","block");    
          $(".jOpener, #floatnav, .pullquote, .pdfLink, .articleSections, .mjToggle, .author-notes, #ref-list-1, #commenting, .commentLink").css("display","none");         
          }

          if (accTyp == 'SHOWLOGIN')
          {
          $(".journalPreviewLogin, #gradientContainer").css("display","block");      
          $(".jOpener, #floatNav, .pullquote, .pdfLink, .articleSections, .mjToggle, .author-notes, #ref-list-1, #commenting, .commentLink").css("display","none");
         
          }
         
      

          if(hasIssueAccess !='true' && accTyp == 'OPEN')
          {
          $(".subscribetext").css("display","none");
$("#ref-list-1, #commenting, #authornotes").css("display","block");
          }

          if(hasIssueAccess =='true' || accTyp == 'OPEN')
{
 $(".subscribetext").css("display","none");
  $(".pdfLink").css("display","inline");}
          }

 else if (metaRestrict == 'false')
  {
 $(".pdfLink, .commentLink").css("display","inline");
$(".subscribetext").css("display","none");
$("#ref-list-1, #commenting, #authornotes").css("display","block");


};
       

         
          });
     

</script><div xmlns:xlink="http://www.w3.org/1999/xlink" id="gradientContainer" style="display:none;"><div class="afpblue"><div id="spopup" style="display: none; position: relative;"><center><p><b>Read the full article.</b></p></center><div class="spopuplist"><ul><li>Get immediate access, anytime, anywhere.</li><li>Choose a single article, issue, or full-access subscription.</li><li>Earn up to 6 CME credits per issue.</li></ul></div><center><table><tr><td style="text-align:center !important;margin:0 auto; padding:0; float:none;"><div class="spopupbottom1">Already a member/subscriber?</div><br/><a href="" class="button simple loginLink" style="margin-top:-15px;">
                                      Log in &gt;&gt;
                                  </a></td><td style="text-align:center !important;margin:0 auto;padding:0; float:none;"><div class="spopupbottom2"> 
                   Purchase Access:<br/><a href="javascript:void(0)" id="create" class="button orange purchaseBoxButton" style="margin-top:5px;margin-bottom:5px;">See My Options</a><a href="#" class="ui-dialog-titlebar-close ui-corner-all modal" role="button"><span class="ui-icon ui-icon-closethick">close</span></a></div><div id="createDialog" class="ui-dialog-content ui-widget-content modalperim" style="width: auto; min-height: 91.04px; height: auto;" scrolltop="0" scrollleft="0"><table><div class="modalcontents"><tr><div class="modalsignin" style="display:block; text-align:right; clear:both; margin-top:-10px;"><p style="margin: 0px 0 5px;">Already a member or subscriber? <a href="" class="loginLink">Log in</a></p></div></tr><div class="modalcol1 effect6"><center><h3 style="margin-top:10px; color:#cf7f00;"> </h3><p class="ribbon"><span>Best Value!</span></p></center><center><p class="purchaseTitle">Get Full Access<br/></p>From $140</center><br/><div><center><a href="/journals/afp/subscriptions/rates.html" class="button orange" style="margin-bottom:5px;">Subscribe</a></center></div><ul><li style="list-style-type: none !important;">Includes:</li><li class="margin-left">Immediate, unlimited access to all AFP content</li><li class="margin-left">More than 130 CME credits per year</li><li class="margin-left">Access to the AFP app</li><li class="margin-left">Print delivery option</li></ul></div><div class="modalcol2 effect6"><center><h3 style="margin-top:10px; color:#cf7f00;"> </h3><p class="purchaseTitle">Access This Issue<br/></p>$39.95</center><br/><div id="container2"><span> </span></div><ul><li style="list-style-type: none !important;">Includes:</li><li class="margin-left">Immediate access to this issue</li><li class="margin-left"><span id="cmeCredit"> </span> CME credits in this issue</li></ul><br/></div><script>
     
$(".ui-dialog.ui-widget.ui-widget-content.ui-corner-all.subscriptionmodal.ui-draggable").addClass("dept");

</script><div class="modalcol3 effect6"><center><h3 style="margin-top:10px; color:#cf7f00;"> </h3><p class="purchaseTitle">
                                               Access This Article<br/></p>$20.95
                                       </center><br/><div id="container1"><span> </span></div><ul><li style="list-style-type: none !important;">Includes:</li><li class="margin-left">Immediate access to this article</li></ul><br/></div></div></table></div></td></tr></table></center></div></div><div id="gradientContents">
                       
                  </div><div id="gradientColor"> 
                       
                  </div></div><div xmlns:xlink="http://www.w3.org/1999/xlink" class="subscribetext" style="display:none;">To see the full article, log in or purchase access.</div><div xmlns:xlink="http://www.w3.org/1999/xlink" class="afpContent"><div class="author-notes neToggle"><h4 style="display:inline-block;">The Authors</h4><a class="neHeader" style="display:inline-block;margin-left:6px;padding:4px;font-size:14px;">show all author info</a><p class="authFirst">NORMAN S. MILLER, M.D., is associate professor of psychiatry and neurology and chief of the division of addiction programs at the University of Illinois School of Medicine, Chicago. He received a medical degree from Howard University, Washington, D.C., and completed a residency in psychiatry at Johns Hopkins Hospital, Baltimore, and a residency in neurology at the University of Minnesota, Minneapolis.<span class="neHide">...</span></p><div class="neContent"><div class="fn"><p class="fn">MARK S. GOLD, M.D., is professor of psychiatry at the University of Florida Brain Institute, Gainesville. He received a medical degree from the University of Florida College of Medicine, Gainesville, and served a residency in psychiatry at Yale University, New Haven, Conn.</p></div><p><span class="italic">Address correspondence to Norman S. Miller, M.D., University of Illinois at Chicago Department of Psychiatry (MC 913), 912 S. Wood Street, Chicago, IL 60612&#x2013;7327. Reprints are not available from the authors</span>.</p></div></div><div class="ref-list" id="ref-list-1"><div class="refList neToggle"><h3 style="display:inline-block;">REFERENCES</h3><a class="neHeader" style="display:inline-block;margin-left:6px;padding:4px;font-size:14px;">show all references</a><p class="refFirst" id="afp19980701p139-b1"><span class="label">1. </span><span class="mixed-citation">U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism. Epidemiology of alcohol use and alcoholrelated consequences. In: Alcohol and health. Eighth special report to the U.S. Congress from the Secretary of Health and Human Services. September 1993:1&#x2013;35.</span><span class="neHide">...</span></p><div class="neContent"><p id="afp19980701p139-b2"><span class="label">2. </span><span class="mixed-citation">Bennett JC, Plum F, eds. Cecil textbook of medicine. 20th ed. Philadelphia: Saunders, 1996.</span></p><p id="afp19980701p139-b3"><span class="label">3. </span><span class="mixed-citation">Adams RD, Victor M, Ropper AH. Principles of neurology. 6th ed. New York: McGraw-Hill, Health Professions Division, 1997.</span></p><p id="afp19980701p139-b4"><span class="label">4. </span><span class="mixed-citation">Miller NS, Gold MS, Smith DE, eds. Manual of therapeutics for addictions. New York: Wiley-Liss, 1997.</span></p><p id="afp19980701p139-b5"><span class="label">5. </span><span class="mixed-citation">American Society of Addiction Medicine. Principles of addiction medicine. Washington, D.C.: The Society, 1994.</span></p><p id="afp19980701p139-b6"><span class="label">6. </span><span class="mixed-citation">Miller NS,
        Gold MS.
         Abuse, addiction, tolerance, and dependence to benzodiazepines in medical and nonmedical populations. <i>Am J Drug Alcohol Abuse</i>.
       1991;17:27&#x2013;37.</span></p><p id="afp19980701p139-b7"><span class="label">7. </span><span class="mixed-citation">Rickels K,
        Schweizer E,
        Case WG,
        Greenblatt DJ.
         Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. <i>Arch Gen Psychiatry</i>.
       1990;47:899&#x2013;907 [Published erratum appears in Arch Gen Psychiatry 1991;48:51]</span></p><p id="afp19980701p139-b8"><span class="label">8. </span><span class="mixed-citation">Schweizer E,
        Rickels K,
        Case WG,
        Greenblatt DJ.
         Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper. <i>Arch Gen Psychiatry</i>.
       1990;47:908&#x2013;15.</span></p><p id="afp19980701p139-b9"><span class="label">9. </span><span class="mixed-citation">Gorelick DA.
         Overview of pharmacologic treatment approaches for alcohol and other drug addiction. Intoxication, withdrawal, and relapse prevention. <i>Psychiatr Clin North Am</i>.
       1993;16:141&#x2013;56.</span></p><p id="afp19980701p139-b10"><span class="label">10. </span><span class="mixed-citation">Gold MS. Pharmacological therapies of opiate addiction. In: Miller NS, Gold MS, eds. Pharmacologic therapies for drug and alcohol addictions. New York: Marcel Dekker, 1995.</span></p><p id="afp19980701p139-b11"><span class="label">11. </span><span class="mixed-citation">Giannini AT. Phencyclidine. In: Miller NS, ed. Comprehensive handbook of drug and alcohol addiction. New York: Dekker, 1991:383&#x2013;94.</span></p><p id="afp19980701p139-b12"><span class="label">12. </span><span class="mixed-citation">Fuller RK,
        Branchey L,
        Brightwell DR,
        Derman RM,
        Emrick CD,
        Iber FL,
        
          et al.
         Disulfiram treatment of alcoholism. A Veterans Administration cooperative study. <i>JAMA</i>.
       1986;256:1449&#x2013;55.</span></p><p id="afp19980701p139-b13"><span class="label">13. </span><span class="mixed-citation">Banys P.
         The clinical use of disulfiram (Antabuse): a review. <i>J Psychoactive Drugs</i>.
       1988;20:243&#x2013;61.</span></p><p id="afp19980701p139-b14"><span class="label">14. </span><span class="mixed-citation">Weddington WW. Methadone maintenance for opioid addiction. In: Miller NS, Gold MS, eds. Pharmacological therapies for drug and alcohol addictions. New York: Dekker, 1995:411&#x2013;18.</span></p><p id="afp19980701p139-b15"><span class="label">15. </span><span class="mixed-citation">Volpicelli JR,
        Alterman AI,
        Hayashida M,
        O'Brien CP.
         Naltrexone in the treatment of alcohol dependence. <i>Arch Gen Psychiatry</i>.
       1992;49:876&#x2013;80.</span></p><p id="afp19980701p139-b16"><span class="label">16. </span><span class="mixed-citation">O'Malley SS,
        Jaffe AJ,
        Chang G,
        Schottenfeld RS,
        Meyer RE,
        Rounsaville B.
         Naltrexone and coping skills therapy for alcohol dependence. A controlled study. <i>Arch Gen Psychiatry</i>.
       1992;49:881&#x2013;7.</span></p><p id="afp19980701p139-b17"><span class="label">17. </span><span class="mixed-citation">O'Malley SS.
         Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse. <i>Alcohol Alcohol</i>.
       1996;31(Suppl 1):77&#x2013;82.</span></p><p id="afp19980701p139-b18"><span class="label">18. </span><span class="mixed-citation">Miller NS. Treatment of the addictions: applications of outcome research for clinical management. New York: Haworth, 1995.</span></p><p id="afp19980701p139-b19"><span class="label">19. </span><span class="mixed-citation">Gerstein DR, Johnson RA, Harwood H, Fountain D, Suter N, Malloy K. Evaluating recovery services: the California Drug and Alcohol Treatment Assessment (CALDATA). Sacramento, Calif.: State of California Department of Drug and Alcohol Programs, 1994.</span></p><p id="afp19980701p139-b20"><span class="label">20. </span><span class="mixed-citation">Iglehart JK.
         The American health care system. Managed care. <i>N Engl J Med</i>.
       1992;327:742&#x2013;7.</span></p><p id="afp19980701p139-b21"><span class="label">21. </span><span class="mixed-citation">Holder HD,
        Blose JO.
         The reduction of health care costs associated with alcoholism treatment: a 14-year longitudinal study. <i>J Stud Alcohol</i>.
       1992;53:293&#x2013;302.</span></p><p id="afp19980701p139-b22"><span class="label">22. </span><span class="mixed-citation">Turnure C. Minnesota Consolidated Fund, annual cost offsets. Minnesota Department of Human Services, 1993.</span></p><p id="afp19980701p139-b23"><span class="label">23. </span><span class="mixed-citation">Chappel JN.
         Long-term recovery from alcoholism. <i>Psychiatr Clin North Am</i>.
       1993;16:177&#x2013;87.</span></p></div></div></div><div class="commenting" id="commenting"><div class="showCommentsLink" style="display:none"><button class="button orange addViewComments">Add/view comments</button></div><div class="hideCommentsLink"><button class="button orange hideComments">Hide comments</button></div><div style="clear:both;line-height:0px;"> </div><div class="comments"><script>
        jQuery(document).ready(function(){
        var loggedIN = Utils.isLoggedIn();
               if(loggedIN == true){
        $(".showCommentsLink").css('display', 'block');      
        }

        });
      </script>
     








      <script type="text/javascript" src="/CommentProject/javascript/jquery.validate.min.js"></script>


      <script type="text/javascript" src="/CommentProject/javascript/socialcommenting.min.js"></script>
      <link media="all" type="text/css" href="/CommentProject/css/socialcommenting.min.css" rel="stylesheet"/>

      <a name="embeddedforumform"></a>
      <div id="divid"></div>

<script type="text/javascript">
        var thisCommentHandle = "/content/aafp" + commentHandle;
        jQuery(document).ready(function(){
        try{
        commentWidgetServerModeratePath = "http://staff.aafp.org/CommentProject"
        aafpCommentWidget(thisCommentHandle , "divid", {
        memberid: Utils.getWebLoginValue()
        , formheader: "Please enter a comment:"
        , loggedin: Utils.isLoggedIn()
        });
        }
        catch(e){
        //console.log("Error: " + e);
        }
        });
      </script>
     
   
 <script type="text/javascript">
          $(document).ready( function() {
         


          $("#commenting").append("<p class=\"commentTerms\" style=\"display:none;\"><i>All comments are moderated and will be removed if they violate our <a href=\"http://www.aafp.org/journals/afp/permissions/terms-use.html\">Terms of Use</a>.</i></p>");
          });
      </script>

</div></div><br/><div id="prevNextLocation"> </div><p class="journalCopyright">
            Copyright © 1998 by the American Academy of Family Physicians.<br/>
            This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact  
             <a href="mailto:afpserv@aafp.org">afpserv@aafp.org</a> for copyright questions and/or permission requests.
          </p></div><script xmlns:xlink="http://www.w3.org/1999/xlink">
          
          $(document).ready(function() {
       

          });

      

          $( ".addViewComments" ).click(function() {

          $(".leaderboardAd, .rightAd, .mobile-ad, .showCommentsLink").attr("style", "display: none !important");
          $(".commentcontainerccomments, .commentcontainercform, .commentTerms, .hideCommentsLink, .EmbeddedForumPosts, .commentAddLink").attr("style", "display: block !important");
      
          });

          $( ".hideComments" ).click(function() {
    
          $(".showCommentsLink").attr("style", "display: block !important");
          $(".leaderboardAd, .rightAd, .mobile-ad").css("display", "");
          $(".commentcontainerccomments, .commentcontainercform, .commentTerms, .hideCommentsLink, .EmbeddedForumPosts, .commentAddLink").attr("style", "display: none !important");
        
          });


          $( ".commentButton" ).click(function() {

          $(".EmbeddedForumPosts, .articleComments").attr("style", "display: block !important");

          });



      </script><script xmlns:xlink="http://www.w3.org/1999/xlink">
     

          $(document).ready(function() {
          var contentType = $("meta[name='content-type-facet']").attr("content");
         


          if  (($("#floatNavLinks").length) && (contentType == 'Article') && (accTyp !== 'DENIED') && (accTyp !== 'SHOWLOGIN')){
        


          $("#floatNav").addClass("showScreen");
          };
          
          if (contentType !== 'Article') {
        

          $("#floatNav").css("display", "none");
          };
          });


</script><script xmlns:xlink="http://www.w3.org/1999/xlink">
     
          $(document).ready(function(){

          var winHigh = $(window).height();

          if (winHigh > 600) {
            var tableHigh = winHigh-100

          $('.journalTable').css('max-height', tableHigh + 'px');
          }
          else {
            var tableHigh = winHigh-50
          $('.journalTable').css('max-height', tableHigh + 'px');
          };

          });

</script><script xmlns:xlink="http://www.w3.org/1999/xlink" type="text/javascript">
$(document).ready(function(){
    $(".mjContent").hide();
    $(".mjHeader").toggle(function(){
        $(this).html('<span style="margin:5px;" class="mobileSectionLink">Jump to section -</span>');
        }, function () {
        $(this).html('<span style="margin:5px;" class="mobileSectionLink">Jump to section +</span>');
    });
    $(".mjHeader").click(function(){
        
        $(this).nextAll(".mjContent").slideToggle();
    });
});
</script><script xmlns:xlink="http://www.w3.org/1999/xlink">
      
      $( ".neHeader" ).click(function() {  
      
       if ($(this).text() == "hide references"){
           $(this).text('show all references');           
           $(this).nextAll(".neContent").first().slideToggle();
            $(this).next('.refFirst').find('.neHide').css('display', 'inline');
         
          }
      
      else if ($(this).text() == "show all references"){
                 
          $(this).next('.refFirst').find('.neHide').css('display', 'none');
          $(this).text('hide references');           
           $(this).nextAll(".neContent").first().slideToggle();
          }
      
     else if ($(this).text() == "hide author info"){        
          $(this).text('show all author info');          
           $(this).nextAll(".neContent").first().slideToggle();
           $(this).next('.authFirst').find('.neHide').css('display', 'inline');
          }
      
       else if ($(this).text() == "show all author info"){
         $(this).next('.authFirst').find('.neHide').css('display', 'none');
          $(this).text('hide author info');          
           $(this).nextAll(".neContent").first().slideToggle();
          }
          
            else if ($(this).text() == "hide all"){
           $(this).text('show all');           
           $(this).nextAll(".neContent").first().slideToggle();
            $(this).next('.neHide').css('display', 'block');
          }
      
       else if ($(this).text() == "show all"){
           $(this).next('.neHide').css('display', 'none');
          $(this).text('hide all');         
           $(this).nextAll(".neContent").first().slideToggle();
          }

});
      </script><script xmlns:xlink="http://www.w3.org/1999/xlink" type="text/javascript">
            $(document).ready(function(){
            var hashAnchor = window.location.hash;

            if($(hashAnchor).is(':hidden'))
            {

            if ($(hashAnchor).closest('.refList').length){
            $(hashAnchor).closest('.neToggle').find('.neHeader:first').text('hide references');
            $(hashAnchor).closest('.neContent').css('display', 'block');
            $(hashAnchor).closest('.refList').find('.neHide').css('display', 'none');
            location.href = hashAnchor

            };
            };
            });
        </script><script xmlns:xlink="http://www.w3.org/1999/xlink" type="text/javascript">
               $("a.bibrRef").click(function (){
               var bibLink = $(this).attr('href');
               if($(bibLink).is(':hidden'))
               {
               $(bibLink).closest('.neToggle').find('.neHeader:first').text('hide references');
               $(bibLink).closest('.neContent').css('display', 'block');
               $(bibLink).closest('.refList').find('.neHide').css('display', 'none');

               };

               });


           </script><script xmlns:xlink="http://www.w3.org/1999/xlink">


          $("#floatRefLink").click(function (){

          var floatRefList = $('#ref-list-1').find('.neContent');

          if($(floatRefList).is(':hidden'))
          {
          $(floatRefList).closest('.neToggle').find('.neHeader:first').text('hide references');
          $(floatRefList).closest('.neContent').css('display', 'block');
          $(floatRefList).closest('.refList').find('.neHide').css('display', 'none');

          };

          });

      </script><script xmlns:xlink="http://www.w3.org/1999/xlink">

          $("#mobRefLink").click(function (){

          var mobRefList = $('#ref-list-1').find('.neContent');

          if($(mobRefList).is(':hidden'))
          {
          $(mobRefList).closest('.neToggle').find('.neHeader:first').text('hide references');
          $(mobRefList).closest('.neContent').css('display', 'block');
          $(mobRefList).closest('.refList').find('.neHide').css('display', 'none');


          };

          });

      </script><script xmlns:xlink="http://www.w3.org/1999/xlink" type="text/javascript">
          var buyName ="afp-july-1-1998-online-access";


          $(".refListHeader").click(function () {

          $header = $(this);
          //getting the next element
          $content = $header.next();
          //open up the content needed - toggle the slide- if visible, slide up, if not slidedown.
          $content.slideToggle(500, function () {
          //execute this after slideToggle is done
          //change text of header based on visibility of content div
          $header.text(function () {
          //change text based on condition
          return $content.is(":visible") ? "Collapse" : "Expand";
          });
          });

          });

      </script><script xmlns:xlink="http://www.w3.org/1999/xlink">
          $(document).ready(function(){
  
          document.getElementById("cmeCredit").innerHTML = prescribedCredit;
          });
      </script>

<div class="afpContent">	














		<script type="text/javascript">
		var addthis_share = { email_template: 'aafp' }
		var addthis_config = {
		     username: "aafponline"
		     , ui_click: true
		     , ui_cobrand: "AAFP"
		     //, services_compact: 'email,gmail,google_plusone_share,reddit,linkedin,instapaper,pocket,evernote,delicious,more'
		     , services_exclude: 'print'
		     }
		</script>
 
 
 
 <div class="sharePrintLinks">
 
<div class="printLinksDiv">
 
 <ul class="printLinks">
  
 			
			
			  <li>
			<img alt="Print page" src="//img.aafp.net/icons/print.png" height="17" width="17" />
		<a href="#" onclick="window.print(); return flase;">PRINT</a></li>
		
		 <li class="commentLink" style="display:none;">
			<img alt="Comments" src="https://www.aafp.org/afp/images/icons/comment20.gif" height="17" width="17" />
		<a href="#commenting" class="shareCommentsLink">COMMENTS</a>
          </li>
         

             <script>
     	$(document).ready(function(){

          if ($('#commenting').length) {
        
          $('.commentLink').css('display', 'inline-block');}

          else {
	
          $('.commentLink').css('display', 'none');
};
     	});
     
          </script> 
          
		
		

         <li class="favoriteLink -js-favorite-btn">
         <a class="-js-favorite-add-btn" href="#" style="display:none;"><i class="fa fa-star-o"></i><span class="_text"> ADD TO FAVORITES</span></a>
         <a class="-js-favorite-remove-btn" href="#" style="display:none;"><i class="fa fa-star"></i><span class="_text"> REMOVE FAVORITE</span></a> 
         	<span class="-js-favorite-msg" style="display:none;"></span>
    		<div id="dialog-confirm" class="-js-favorite-dialog" title="Remove Favorites Link?" style="display: none;">
        	<p>This page will be removed from your Favorites Links. Are you sure?</p></div> 
         </li>
		
		</ul>
 </div>
 
 
 
 
 
 
 
 
 <div class="shareLinksDiv">		
			
            
			

	 <ul class="shareLinks">
	<li>SHARE</li>
	<li><a title="Bookmark and Share" class="addthis_button_compact"><img src="//img.aafp.net/icons/addthis.png" height="17" width="17" /></a></li>
	<li><a title="Share to Facebook" class="addthis_button_facebook"><img src="//img.aafp.net/icons/facebook.png" height="17" width="17" /></a></li>
	<li><a title="Share to Twitter" class="addthis_button_twitter"><img src="//img.aafp.net/icons/twitter.png" height="17" width="17" /></a>		</li>	
			</ul>
			
	

</div>

		






<script type="text/javascript">
$(document).ready(function() {
	$('#aafp-sign-in').attr('href',loginInfo.signInPageLinkInfo.url);
	$('.AtomFeedLink').unbind("click").bind("click", function (event) {
    	sconclickevent('link to medicine by numbers rss - https://www.aafp.org/rest/afp/medbynumbersdeptfeed.atoms.xml'); 
    });
});
</script>

<div class="clearfix"></div>

</div>

	<script src="https://s7.addthis.com/js/300/addthis_widget.js#async=1" type="text/javascript"></script>
	
	  <script type="text/javascript">
    // Call this function once the rest of the document is loaded
    function loadAddThis() {
        addthis.init()
    }
</script> 

<script>
	var shareToolsClone = $(".sharePrintLinks").clone();
	shareToolsClone.find('#dialog-confirm').attr('id', 'dialog-confirm-2');
	$("#shareToolsLocation").html(shareToolsClone);
	
	loadAddThis();
</script>
            
      
          
<div class="clearfix"></div>





</div>

					<div class="align-center">
						<p>Want to use this article elsewhere? <a href="https://www.aafp.org/journals/afp/permissions/requests.html">Get Permissions</a></p>
					</div><!-- align-center -->

					<div class="clearfix"></div>

				</div><!-- container -->

			</div><!-- eight-column -->

	
		</div><!-- bucket -->

		 






<div class="bucket short" id="column-wrap">








  <div id='div-gpt-ad-right' style="text-align:center;" class="rightAd">
  <a href="https://www.aafp.org/journals/afp/advertisers/rates-policies/online-policies.html" class="advert-title"  target="_blank">Advertisement</a><br/>
    <script type='text/javascript'>
      googletag.cmd.push(function() { googletag.display('div-gpt-ad-right'); });
    </script>
  </div>
















	
          <div class="block four-column drop-shadow no-margin tablet-no-resize">
			<div class="container white">
           <p class="title">More in <i>AFP</i></p>
            <div class="content" style="display:block;">
            <br />

          
           <h4 class="relatedContent">Editor's Collections</h4>
             <hr class="relatedContent" />
             <ul class="relatedContent">
              
            
	    		        
	            	<li><strong><a id="relContentLink" href="/afp/topicModules/viewTopicModule.htm?topicModuleId=1">Alcohol Abuse and Dependence</a></strong></li>
	            
            
            
            	
            	</ul>
            


		   
       <h4 class="relatedContent">Related Content</h4>
       <hr class="relatedContent" />
             <ul class="relatedContent">
            
	            	<li><strong><a id="relContentLink" href="/afp/viewRelatedDocumentsByKeyword.htm?keywordId=2227">Alcohol Abuse and Dependence</a></strong></li>
            
	            	<li><strong><a id="relContentLink" href="/afp/viewRelatedDocumentsByKeyword.htm?keywordId=2448">Substance Abuse</a></strong></li>
            
              </ul>
       
       



	         <!-- -->
 
  
            </div>
              </div>
    </div>

    
    
    
    
    
    
    			<div class="block four-column drop-shadow no-margin tablet-no-resize">
			<div class="container white">

			<p class="title">More in Pubmed</p>

 <div class="content" style="display:block;">
<br />
						<ul class="bold">
							<li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9672434">Citation</a></li>
							<li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Display&amp;dopt=pubmed_pubmed&amp;from_uid=9672434">Related Articles</a>
							</li>
						</ul>

					</div>

    </div>    
    </div>
  
  
  <script>

	$(document).ready(function(){
	    $('#relContentLink').click(function(){
	    	sconclickeventwithnum('AFP:side:relatedContent', 31, 31);
	    });
	});
  </script>
    











    
    
    			<div class="block four-column drop-shadow no-margin tablet-no-resize">
			<div class="container white">

			 <p class="title">MOST RECENT ISSUE</p>

 <div class="content" style="display:block;">
<br />
		


 
<a href="/afp/2018/0901/"><img src="/afp/2018/0901/cover-etoc.jpg" style="width:100px;margin-bottom:10px;margin-right:10px;float:left;"/></a>
			

<div>
<p><b>Sep 1, 2018</b></p>	
 <p class="smalltext">Access the latest issue of <i>American Family Physician</i></p>

<p style="margin-top:30px;"><a class="button-tertiary" style="float:none;" href="/afp/2018/0901/">Read the Issue</a></p>

 <br />
</div>
					</div>

    </div>    
    </div> 

 
 
 










	<div class="calloutbox journalRight">

<div class=" mobile  highlights flex-default">
	<div class="container gradient-white">
		
		<div class="par parsys">
		<div class="text parbase section"> 
    	
    	
    		<h4>Email Alerts</h4>
<p>Don't miss a single issue. Sign up for the free <i>AFP</i> email table of contents.</p>
<p><a class="button simple emailSignUp" href="https://www.aafp.org/journals/afp/subscriptions/by-email.html" style="margin-left:0px;">Sign Up Now</a></p>
    	
    	
    </div>
</div>

		
	</div>
</div>
</div>	








<div class="block four-column drop-shadow no-margin tablet-no-resize" id="floatNav">
			<div class="container white">

			<p class="title">Navigate this Article</p>

 <div class="content">
  <br />
  <span id="floatNavSpace"></span>
  
  
 



 </div>
  </div>
</div>	

<script>

$(document).ready(function() {

	if (document.getElementById("floatNavLinks")) {
		
		   $("#floatNavLinks").appendTo("#floatNavSpace");
		   
		   $("#floatNav").show;
	};
	
});
</script>

<script>
$(document).ready(function() {
	
	
	
      offsetF = $("#floatNav").offset().top;     
      sideBarH = $("#floatNav").height();
    var topPadding = 20; 
    	
      
     function scrollThis() {     
    	 
 
    	 
     
    	 
    	
    	    var maxPos = $("#leaderBoardAd").height() + $("#header-container").height() + $(".wide").height() - (sideBarH);
            
            var maxPosB = $(".wide").offset().top + $(".wide").height() - (sideBarH + offsetF + 50);
                        
            var newPos = ($(document).scrollTop() - offsetF) + topPadding;
            
                        
            if ($(document).scrollTop() > offsetF) {
            	
            	
                if (newPos > maxPosB) {
                	
                	
                	 
                	 $("#floatNav").stop().animate({
                         marginTop: (maxPosB - 20)
                     });
                	 
                	 
                }
                
                else{
                	  
           
                $("#floatNav").stop().animate({
                    marginTop: newPos
                });
             
                }
               
            } 
            
            else {
            
                $("#floatNav").stop().animate({
                    marginTop: 0
                });
            };
            
       
        };
   
       
    	$(window).scroll(function() {          
    		
    		
    		scrollThis();
    		
    	});
        
        
    	$(window).resize(function() {   
    		  
    	     var wideNess = $(".wide").offset().top + $(".wide").height() - (($("#floatNav").height()) + offsetF + 50);
             var floatMarg = parseInt($("#floatNav").css('margin-top'));
         
            
            
            
             		
             		if(wideNess < floatMarg){
             	
             			
             			 $("#floatNav").css('margin-top', wideNess);
                    	 
             		}; 
    		
    		scrollThis();
    		
    		});
        
    });


  

	

	
    
	</script>	
	
	 
	
	
	<script>

	</script>
	
		<script>	
	$(document).ready(function() {
		
			
			
			$('a.floater').unbind("click").bind("click", function (event) {
								
				srcText = "side:" + jQuery.trim($(this).text());		        	
	        	
	    		var s=s_gi(s_account);	    		
	    		s.prop31 = srcText;
	    		
	    		s.prop33=(s.pageName + ":" + s.prop31); 
	    		
	    		s.linkTrackVars="prop31,prop33";
	    		s.linkTrackEvents="none";
	    	
			
			});
			
			
	        
		 });
	</script>
	
	
	


</div>


		<div class="clearfix"></div>

		

	</section><!-- content -->

	<div class="clearfix"></div>

</div><!-- main -->

     <div class="clearfix"></div>  
     
    
     






<div class="outline" id="prevNextBox" style="display:none; margin-bottom:20px;">

   <div id="issueCoverContainer" class="hideMobileOnly">
    <img id="issueCover" src="/afp/1998/0701/afp19980701-cover.jpg" style="float:left;margin-right:10px;width:125px;" />
  </div>
   
 <div id="prevNextBoxContent">   
  <h2 style="margin-bottom:20px;">Continue reading from <a href="/afp/1998/0701/" alt="Jul 01, 1998 Issue" title="Jul 01, 1998 Issue">July 1, 1998</a></h2>


 <p><b>
Previous: <a id="prevArticle" href="/afp/1998/0701/p130.html" alt="Indications for Anticoagulation in Atrial Fibrillation" title="Indications for Anticoagulation in Atrial Fibrillation">Indications for Anticoagulation in Atrial Fibrillation</a></b></p>


    
    
<p><b>Next: <a id="nextArticle"  href="/afp/1998/0701/p153.html" alt="Assessment of Abnormal Growth Curves" title="Assessment of Abnormal Growth Curves">Assessment of Abnormal Growth Curves
</a></b></p>

  

  <p><b><a href="/afp/1998/0701/" alt="Jul 01, 1998 Issue" title="Jul 01, 1998 Issue">View the full table of contents &#62;&#62;</a></b></p>
  </div>

  <div class="clearfix"></div>

    </div>

                
                     


<script>


$("#issueCover").error(function(){
  $("#issueCover", "#issueCoverContainer").css('display','none');
  $("#prevNextBoxContent").css('margin-left','0px');
});

$(document).ready(function(){



$('#prevNextBox').insertBefore('#prevNextLocation');
$('#prevNextBox').css('display', 'block');


    $('#prevArticle').unbind("click").bind("click", function (event) {
    	sconclickevent('AFP Previous Page'); 
    });
    $('#nextArticle').unbind("click").bind("click", function (event) {
    	sconclickevent('AFP Next Page');
    });
});
</script>



 
   
 
 	 








<div id="aafpSyndicatedBreadcrumbs" style="display:none;">
 <p><a href="https://www.aafp.org">Home</a> 
 <span>/</span> <a href="https://www.aafp.org/journals.html">Journals</a> 
 <span>/</span> <a href="/afp/" style="text-transform:uppercase">afp</a> 
 <span>/</span> <a href="/afp/1998/0701/">Vol. 58/No. 1(July 1, 1998)</a> 
 <span>/</span>  
    
      Management of Withdrawal Syndromes and Relapse Prevention in Drug and Alcohol Abuse
    
 </p>
</div> 


  
        <!-- breadcrumbs-container -->

       
     

        <!--#include virtual="includes/mobile-footer.html" -->

 <script type="text/javascript" src="https://www.aafp.org/journals/afp.footer.js"></script>	 
 


   	<script type="text/javascript">
   		var cmeExpired = "true";
   	</script>
    
      
        <script>
     $(document).ready(function() {
(function($){
	$.getQuery = function( query ) {
		query = query.replace(/[\[]/,"\\\[").replace(/[\]]/,"\\\]");
		var expr = "[\\?&]"+query+"=([^&#]*)";
		var regex = new RegExp( expr );
		var results = regex.exec( window.location.href );
		if( results !== null ) {
			return results[1];
			return decodeURIComponent(results[1].replace(/\+/g, " "));
		} else {
			return false;
		}
	};
})(jQuery);
 
// Document load
$(function(){
	var appTraffic = $.getQuery('mobile');
 
	
	if(appTraffic == 'afpMobile')
	{
   
	
$(".primary-nav, .global-search, .mobilenav, #utility-nav").css({'visibility':'hidden'});
$(".share, .breadcrumbs, #footer-container, .mobile-navigation, .pvNxContainer, .sharePrintLinks, .main-nav").css({'display':'none'});

	
} 
});
     });
  </script>
  
        <script>
     
          $(document).ready(function() {
          var contentType = $("meta[name='content-type-facet']").attr("content");
         


          if  (($("#floatNavLinks").length) && (contentType == 'Article') && (accTyp !== 'DENIED') && (accTyp !== 'SHOWLOGIN')){
        


          $("#floatNav").addClass("showScreen");
          };
          
          if (contentType !== 'Article') {
        

          $("#floatNav").css("display", "none");
          };
          });

      </script>
  

	<script>
		jQuery( document ).ready(function() {
			fo = {
				env: "prod",
			  	isAuthor: false	
			}
			runFavorites(fo);
		});
		</script>
 
  </body>
</html>